WO2020070063A2

WO2020070063A2 - Detergent compositions and uses thereof

Info

Publication number: WO2020070063A2
Application number: PCT/EP2019/076439
Authority: WO
Inventors: Lilian Eva Tang Baltsen; Rebecca Munk VEJBORG; Klaus GORI
Original assignee: Novozymes A/S
Priority date: 2018-10-01
Filing date: 2019-09-30
Publication date: 2020-04-09
Also published as: US20210340466A1; WO2020070063A3

Abstract

The present invention relates to compositions such as cleaning compositions comprising a mix of enzymes including a DNase and a hexosaminidase. The invention further relates to use of compositions comprising such enzymes in cleaning processes.

Description

DETERGENT COMPOSITIONS AND USES THEREOF

Reference to a Sequence Listing

This application contains a Sequence Listing in computer readable form, which is incorporated herein by reference.

Background of the Invention

The present invention relates to compositions such as cleaning compositions comprising a mix of enzymes. The invention further relates to use of compositions comprising such enzymes in cleaning processes and/or for deep cleaning of biofilm soiling, and methods for removal or reduction of biofilm related soiling.

Description of the Related Art

Enzymes have been used in detergents for decades. Usually a cocktail of various enzymes is added to detergent compositions. The enzyme cocktail often comprises various enzymes, wherein each enzyme targets a specific substrate, e.g. amylases are active towards starch stains, proteases towards protein stains and so forth. Textiles surface and hard surfaces, such as dishes or the inner space of a laundry machine enduring a number of wash cycles, become soiled with many different types of soiling which may compose of proteins, grease, starch etc. One type of soiling may be organic matter, such as biofilm, extracellular polymeric substance (EPS), etc. Organic matter comprises different molecules such as dead cells, sebum and other body soiling, polysaccharides, extracellular DNA (eDNA), and proteins. Some types of organic matter, e.g. bodysoils and biofilm, may be sticky or glueing, which when present on textile attracts soils and may cause redeposition or backstaining of soil resulting in a greying of the textile. Additionally, organic matters such as biofilms often cause malodor issues as various malodor molecules can be adhered by the polysaccharides, eDNA and proteins in the complex extracellular matrix and be slowly released to cause a noticeable malodor issue.

Enzymes having hexosaminidase activity include Dispersins such as Dispersin B (DspB), which is b-N-acetylglucosaminidases belonging to the Glycoside Hydrolase 20 family. Enzymes having hexosaminidase activity include chitinase, and the use of such enzymes is described in WO 98/50512 (Procter and Gamble). WO 2004/0611 17 A2 (Kane Biotech Inc) describes compositions comprising DspB for reducing and preventing biofilm caused by poly-N- acetylglucosamine-producing bacteria and describes the use of the compositions comprising DspB for reduction/ removing biofilm on medical devices and for wound care.

WO 2015/155350 (Novozymes A/S) discloses the use of a polypeptide having DNase activity for preventing, reducing or removing a biofilm component e.g. DNA from an item, wherein the polypeptide is obtained from a fungal source such as Aspergillus oryzae and the item is a textile.

WO 2014/087011 (Novozymes A/S) discloses the use of a polypeptide having DNase activity for preventing, reducing or removing a biofilm component e.g. DNA from an item, wherein the polypeptide is obtained from a bacterial source such as Bacillus.

WO 2017/059082 (Novozymes A/S) discloses the use of a polypeptide having DNase activity for preventing, reducing or removing a biofilm component e.g. DNA from an item.

However, there is still a need for cleaning compositions which effectively prevent, reduce or remove components of organic soiling, an effect also described in the present application as “deep cleaning”. The present invention provides new compositions fulfilling such need.

Summary of the Invention

In a first aspect, the present invention relates to a cleaning composition comprising:

a) a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase, e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase; or

b) a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase, e.g. a dispersin, and an RNase;

and a cleaning component.

In a second aspect, the present invention relates to a cleaning composition comprising a DNase, an RNase, optionally a polypeptide having protease activity, and a cleaning component.

In a third aspect, the present invention relates to cleaning composition comprising at least 0.01 ppm DNase, at least 0.01 ppm hexosaminidase, at least 0.01 ppm of a glycosyl hydrolase classified as a Glyco_hydro_1 14 and at least one cleaning component, wherein the cleaning component comprises at least a surfactant; and optionally a builder and/or a bleach component.

In a fourth aspect, the present invention relates to cleaning composition comprising at least 0.01 ppm DNase, at least 0.01 ppm hexosaminidase, at least 0.01 ppm RNase, optionally at least 0.01 ppm protease, and at least one cleaning component, wherein the cleaning component comprises at least a surfactant; and optionally a builder and/or a bleach component.

The present invention further relates to a cleaning composition comprising at least 0.01 ppm DNase, at least 0.01 ppm hexosaminidase, at least 0.01 ppm of a glycosyl hydrolase classified as a Glyco_hydro_1 14 and at least one cleaning component, wherein the cleaning component is selected from a group consisting of:

a. 0.1 to 60 wt% of at least one surfactant;

b. 0 to 50 wt% of a builder; and

c. 0 to 20 wt% of a bleach component,

and combinations thereof.

The present invention further relates to a cleaning composition comprising at least 0.01 ppm DNase, at least 0.01 ppm hexosaminidase, at least 0.01 ppm RNase, optionally at least 0.01 ppm protease, and at least one cleaning component, wherein the cleaning component is selected from a group consisting of:

a. 0.1 to 60 wt% of at least one surfactant;

b. 0 to 50 wt% of a builder; and

c. 0 to 20 wt% of a bleach component,

and combinations thereof.

The invention further relates to the use of the cleaning composition for cleaning of an item, wherein the item is a textile or a surface. The invention further relates to the use of a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin; a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component for cleaning of an item, wherein the item is a textile or a surface. The invention further relates to the use of a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin; an RNase and a cleaning component for cleaning of an item, wherein the item is a textile or a surface.

The invention further relates to a kit intended for cleaning, wherein the kit comprises a solution of an enzyme mixture comprising a DNase, a hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase, or an enzyme mixture comprising a DNase, a hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin and an RNase.

The invention further relates to a method of cleaning an item, comprising the steps of:

a) contacting the item with a wash liquor solution comprising an enzyme mixture comprising at least 0.0001 ppm of a DNase, at least 0.0001 ppm of a hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin, at least 0.0001 ppm of a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase; and a cleaning component, or with a wash liquor solution comprising an enzyme mixture comprising at least 0.0001 ppm of a DNase, at least 0.0001 ppm of a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, at least 0.0001 ppm of an RNase and a cleaning component, wherein the cleaning component comprises at least a surfactant; and optionally a builder and/or a bleach component; and

b) optionally rinsing the item,

wherein the item is preferably a textile.

Definitions

Biofilm is produced by any group of microorganisms in which cells stick to each other or stick to a surface, such as a textile, dishware or hard surface or another kind of surface. These adherent cells are frequently embedded within a self-produced matrix of extracellular polymeric substance (EPS). Biofilm EPS is a polymeric conglomeration generally composed of extracellular DNA, proteins, and polysaccharides. Biofilms may form on living or non-living surfaces. The microbial cells growing in a biofilm are physiologically distinct from planktonic cells of the same organism, which, by contrast, are single-cells that may float or swim in a liquid medium. Bacteria living in a biofilm usually have significantly different properties from planktonic bacteria of the same species, as the dense and protected environment of the film allows them to cooperate and interact in various ways. One benefit of this environment for the microorganisms is increased resistance to detergents and antibiotics, as the dense extracellular matrix and the outer layer of cells protect the interior of the community. On laundry- biofilm- producing bacteria can be found among the following species: Acinetobactersp., Aeromicrobium sp., Brevundimonas sp., Microbacterium sp., Micrococcus luteus, Pseudomonas sp., Staphylococcus epidermidis, and Stenotrophomonas sp. On hard surfaces, biofilm-producing bacteria can be found among the following species: Acinetobacter sp., Aeromicrobium sp., Brevundimonas sp., Microbacterium sp., Micrococcus luteus, Pseudomonas sp., Staphylococcus epidermidis, Staphylococcus aureus and Stenotrophomonas sp. In one aspect, the biofilm producing strain is Brevundimonas sp. In one aspect, the biofilm producing strain is Pseudomonas alcaliphila or Pseudomonas fluorescens. In one aspect, the biofilm producing strain is Staphylococcus aureus.

By the term “deep cleaning” is meant disruption, removal or reduction of components of organic matter, e.g. biofilm, such as polysaccharides, proteins, DNA, soil or other components present in the organic matter.

Cleaning component: The term“cleaning component” as used herein refers to a component that is different from the DNase, the RNase, the glycosyl hydrolase or the hexosaminidase. The precise nature of the cleaning component, and levels of incorporation thereof, will depend on the physical form of the composition and the nature of the operation for which it is to be used. Suitable cleaning components include, but are not limited to the components described below such as surfactants, builders, flocculating aid, chelating agents, dye transfer inhibitors, other enzymes, enzyme stabilizers, enzyme inhibitors, catalytic materials, bleach activators, hydrogen peroxide, sources of hydrogen peroxide, preformed peracids, polymeric agents, clay soil removal/anti-redeposition agents, brighteners, suds suppressors, dyes, perfumes, structure elasticizing agents, fabric softeners, carriers, hydrotropes, builders and co-builders, fabric hueing agents, anti-foaming agents, dispersants, processing aids, and/or pigments.

Cleaning Composition: The term“cleaning composition” refers to compositions that find use in the removal of undesired compounds from items to be cleaned, such as textiles. The cleaning composition may be a detergent composition and may be used to e.g. clean textiles for both household cleaning and industrial cleaning. The term encompasses any materials/compounds selected for the particular type of cleaning composition desired and the form of the product (e.g., liquid, gel, powder, granulate, paste, or spray compositions) and includes, but is not limited to, detergent compositions (e.g., liquid and/or solid laundry detergents and fine fabric detergents; fabric fresheners; fabric softeners; and textile and laundry pre-spotters/pretreatment). In addition to containing the enzymes of the invention, the detergent formulation may contain one or more additional enzymes (such as proteases, amylases, lipases, cutinases, cellulases, endoglucanases, xyloglucanases, pectinases, pectin lyases, xanthanases, peroxidases, haloperoxygenases, catalases and mannanases, or any mixture thereof), and/or detergent adjunct ingredients such as surfactants, builders, chelators or chelating agents, bleach system or bleach components, polymers, fabric conditioners, foam boosters, suds suppressors, dyes, perfume, tannish inhibitors, optical brighteners, bactericides, fungicides, soil suspending agents, anti-corrosion agents, enzyme inhibitors or stabilizers, enzyme activators, transferase(s), hydrolytic enzymes, oxido reductases, bluing agents and fluorescent dyes, antioxidants, and solubilizers. The term “cleaning composition” is used interchangeably with “detergent composition”. The cleaning composition of the present invention can be diluted with water to form a wash liquor solution upon application.

The term“hard surface cleaning” is defined herein as cleaning of hard surfaces wherein hard surfaces may include floors, tables, walls, roofs etc. as well as surfaces of hard objects such as cars and dishes. Dishwashing includes but is not limited to cleaning of plates, cups, glasses, bowls, cutlery such as spoons, knives, forks, serving utensils, ceramics, plastics, metals, china, glass and acrylics.

The term“wash performance” is used as an enzyme’s ability to remove stains present on the object to be cleaned during e.g. wash or hard surface cleaning.

The term“whiteness” is defined herein in relation to greying or yellowing of a textile. Loss of whiteness may be due to removal of optical brighteners/hueing agents. Greying and yellowing can be due to soil redeposition, body soils, colouring from e.g. iron and copper ions or dye transfer. Whiteness might include one or several issues from the list below: colourant or dye effects; incomplete stain removal (e.g. body soils, sebum etc.); redeposition (greying, yellowing or other discolourations of the object) (removed soils reassociate with other parts of textile, soiled or unsoiled); chemical changes in textile during application; and clarification or brightening of colours.

The term“laundering” relates to both household laundering and industrial laundering and means the process of treating textiles with a solution containing a cleaning or detergent composition of the present invention. The laundering process can for example be carried out using e.g. a household or an industrial washing machine or can be carried out by hand.

By the term’’malodor” is meant an odor which is not desired on clean items. The cleaned item should smell fresh and clean without malodors adhered to the item. One example of malodor is compounds with an unpleasant smell, which may be produced by microorganisms. Another example of unpleasant smells can be sweat or body odor adhered to an item which has been in contact with human or animal. Another example of malodor can be the odor from spices which stick to items, for example curry or other spices which smell strongly.

The term“mature polypeptide” means a polypeptide in its mature form following N-terminal processing (e.g., removal of signal peptide). The term“textile” means any textile material including yarns, yarn intermediates, fibers, non- woven materials, natural materials, synthetic materials, and any other textile material, fabrics made of these materials and products made from fabrics (e.g., garments and other articles). The textile or fabric may be in the form of knits, wovens, denims, non-wovens, felts, yarns, and towelling. The textile may be cellulose-based such as natural cellulosics, including cotton, flax/linen, jute, ramie, sisal or coir or manmade cellulosics (e.g. originating from wood pulp) including viscose/rayon, cellulose acetate fibers (tricell), lyocell or blends thereof. The textile or fabric may also be non-cellulose-based such as natural polyamides including wool, camel, cashmere, mohair, rabbit and silk or synthetic polymers such as nylon, aramid, polyester, acrylic, polypropylene and spandex/elastane, or blends thereof as well as blends of cellulose based and non-cellulose based fibers. Examples of blends are blends of cotton and/or rayon/viscose with one or more companion material such as wool, synthetic fiber (e.g. polyamide fiber, acrylic fiber, polyester fiber, polyvinyl chloride fiber, polyurethane fiber, polyurea fiber, aramid fiber), and/or cellulose-containing fiber (e.g. rayon/viscose, ramie, flax/linen, jute, cellulose acetate fiber, lyocell). Fabric may be conventional washable laundry, for example stained household laundry. When the term fabric or garment is used it is intended to include the broader term textiles as well.

The term “variant” means a polypeptide having the activity of the parent or precursor polypeptide and comprising an alteration, i.e., a substitution, insertion, and/or deletion, at one or more positions compared to the precursor or parent polypeptide. A substitution means replacement of the amino acid occupying a position with a different amino acid; a deletion means removal of the amino acid occupying a position; and an insertion means adding an amino acid adjacent to and immediately following the amino acid occupying a position.

Sequence identity: The relatedness between two amino acid sequences or between two nucleotide sequences is described by the parameter“sequence identity”. For purposes of the present invention, the sequence identity between two amino acid sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet. 16: 276-277), preferably version 6.6.0 or later. The parameters used are a gap open penalty of 10, a gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix. The output of Needle labeled“longest identity” (obtained using the -nobrief option) is used as the percent identity and is calculated as follows:

(Identical Residues x 100)/(Length of Alignment - Total Number of Gaps in Alignment).

NUC1 , NUC1 A DNase: The term includes DNases comprising a certain domain. The domain termed NUC1 and polypeptides of this domain are in addition to having DNase activity, characterized by comprising certain motifs e.g. one or more of the motifs

[F/L/Y/I]A[N/R]D[L/I/P/V] (SEQ ID NO: 100) or C[D/N]T[A/R] (SEQ ID NO: 101 ); the letters indicate amino acids in one letter code thus F is phenylalanine, L is leucine, A is alanine, N is asparagine, D is aspartic acid, I is isoleucine, V is valine, H is histidine, G is glycine, C cysteine, T is threonine, R is arginine and so forth. The brackets indicate that the amino acids within the bracket are alternatives. The NUC1_A domain share the common motif [D/Q][I/V]DH (SEQ ID NO 102).

Detailed Description of the Invention

Various enzymes are applied in cleaning processes, each targeting specific types of soiling such as protein, starch and grease soiling. Enzymes are now standard ingredients in detergents for laundry and dishwashing. The effectiveness of these commercial enzymes provides cleaning compositions such as detergents which remove much of the soiling. However, organic matters such as food material, bodysoil, sebum, dead cell material and EPS (extracellular polymeric substances) comprised in much biofilm constitute a challenging type of stains due to the complex nature of such organic matters. Such stains are difficult to effectively remove or reduce using commercially available cleaning compositions. Organic stains such as body soils, cell debris, sebum biofilm etc. may be composed of polysaccharides (exopolysaccharides) and proteins, but may also include other macro-molecules such as eDNA, lipids and other organic substances. Organic matter like biofilm may be sticky or glueing, which when present on textile may give rise to redeposition or backstaining of soil, resulting in a greying of the textile. Another drawback of organic matter is malodor associated with organic matter e.g. biofilm. Further, when dirty laundry items are washed together with less dirty laundry items the dirt present in the wash liquor tends to stick to organic matter, e.g. bodysoiling or biofilm, as a result, with the result that the laundry item may be more“soiled” after wash than before wash. This effect may also be termed re- deposition.

The composition of the invention is preferably a cleaning composition comprising at least one DNase, at least one hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, at least one glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase; or the composition comprises a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and optionally a protease. Examples of useful DNases, hexosaminidases, glycosyl hydrolases classified as Glyco_hydro_1 14 hydrolases and RNases are mentioned below in the sections “Polypeptides having DNase activity”, “Polypeptides having hexosaminidase activity”,“Polypeptide classified as Glyco_hydro_1 14 glycosyl hydrolases” and “Polypeptides having RNase activity (RNase)” respectively.

The compositions of the invention comprising a blend of DNase, hexosaminidase and glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase or comprising a blend of DNase, hexosaminidase, RNase and optionally a protease are effective in reducing or removing organic components and soiling from organic matter. Polypeptides having DNase activity

The term“DNase” means a polypeptide having DNase activity that catalyzes the hydrolytic cleavage of phosphodiester linkages in a DNA backbone, thus degrading DNA. The term “DNase” and the expression “a polypeptide with DNase activity” are used interchangeably throughout the application. For purposes of the present invention, DNase activity is determined according to the procedure described in the Assay I or IV.

Preferably the DNase is selected from any of the enzyme classes E.C. 3.1 .21.X, where X = 1 , 2, 3, 4, 5, 6, 7, 8 or 9, e.g. Deoxyribonuclease I, Deoxyribonuclease IV, Type I site-specific deoxyribonuclease, Type II site-specific deoxyribonuclease, Type III site-specific deoxyribonuclease, CC-preferring endo-deoxyribonuclease, Deoxyribonuclease V, T(4) deoxyribonuclease II, T(4) deoxyribonuclease IV or E.C. 3.1 .22.Y where Y = 1 , 2, 4 or 5, e.g. Deoxyribonuclease II, Aspergillus deoxyribonuclease K(1 ), Crossover junction endo- deoxyribonuclease, Deoxyribonuclease X.

Preferably, the polypeptide having DNase activity is obtained from a microorganism and the DNase is a microbial enzyme. The DNase is preferably of fungal or bacterial origin.

The DNase may e.g. be obtainable from a species of Bacillus, such as a Bacillus licheniformis, Bacillus subtilis, Bacillus ho koshii, Bacillus horneckiae, Bacillus cibi, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi, Bacillus luciferensis, Bacillus sp. SA2-6.

The DNase may also be obtained from any of the following: Pyrenochaetopsis sp., Vibrissea flavovirens, Setosphaeria rostrate, Endophragmiella valdina, Corynespora cassiicola, Paraphoma sp., Monilinia fructicola, Curvularia lunata, Penicillium reticulisporum, Penicillium quercetorum, Setophaeosphaeria sp., Alternaria sp., Trichoderma reesei, Chaetomium thermophilum, Scytalidium thermophilum, Metapochonia suchlasporia, Daldinia fissa, Acremonium sp. Acremonium dichromosporum, Sarocladium sp., Metarhizium sp., Isaria tenuipes Scytalidium circinatum, Metarhizium lepidiotae, Thermobispora bispora, Sporormia fimetaria, Pycnidiophora cf. dispera, Clavicipitaceae sp., Westerdykella sp., Humicolopsis cephalosporioides, Neosartorya massa, Roussoella intermedia, Pleosporales, Phaeosphaeria or Didymosphaeria futilis.

The DNases to be used in a composition of the invention preferably belong to the NUC1 group of DNases. The NUC1 group of DNases comprises polypeptides which in addition to having DNase activity, may comprise one or more of the motifs [T/D/S][G/N]PQL (SEQ ID NO 69), [F/L/Y/I]A[N/R]D[L/I/P/V] (SEQ ID NO: 70), or C[D/N]T[A/R] (SEQ ID NO: 71 ). One embodiment of the invention relates to a composition comprising polypeptides having DNase activity, wherein the polypeptides comprise one or more of the motifs [T/D/S][G/N]PQL (SEQ ID NO 69), [F/L/Y/I]A[N/R]D[L/I/P/V] (SEQ ID NO: 70) or C[D/N]T[A/R] (SEQ ID NO: 71 ).

The DNases of the invention preferably comprise a NUC1_A domain [D/Q][I/V]DH (SEQ ID

NO 72). In addition to comprising any of the domains [T/D/S][G/N]PQL, [F/L/Y/I]A[N/R]D[L/I/PA/] or C[D/N]T[A/R] the polypeptides having DNase activity to be used in a composition of the invention may belong to the NUC1_A domain and may share the common motif [D/Q][I/V]DH (SEQ ID NO 72). One embodiment the invention relates to compositions comprising polypeptides which comprise one or more motifs selected from the motifs [T/D/S][G/N]PQL, [F/L/Y /l]A[N/R] D[L/I/P/V] , C[D/N]T[A/R] and [D/Q][IA/]DH, wherein the polypeptides have DNase activity. Such DNases to be added to a composition of the invention preferably belong to the group of DNases comprised in the GYS-clade, which are NUC1 and NUC1_A DNases further comprising the conservative motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) and/or ASXNRSKG (SEQ ID NO: 74) and which share similar structural and functional properties. The DNases of the GYS-clade are preferably obtained from the Bacillus genus.

In one embodiment the DNase to be added in the cleaning composition of the invention is a polypeptide of the GYS clade having DNase activity, optionally wherein the polypeptide comprises one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) and wherein the polypeptide is selected from the group consisting of:

a) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 ,

b) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2,

c) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3,

d) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4,

e) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5,

f) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6,

g) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7,

h) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8,

i) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9,

j) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10,

k) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 11 ,

L) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 12, m) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13,

n) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 14,

o) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 15,

p) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 16,

q) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 17,

r) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 18,

s) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 19,

t) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 20,

u) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 21 ,

v) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 22,

w) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 23,

x) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and

y) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25.

Polypeptides having DNase activity and which comprise the GYS-clade motifs have shown particularly good cleaning properties, e.g. the DNases are particularly effective in removing or reducing components of organic matter, such as biofilm associated DNA, from an item such as a textile or a hard surface.

In one embodiment the DNases to be added in a composition of the invention preferably belong to the group of DNases comprised in the NAWK-clade, which are NUC1 and NUC1_A DNases further comprising the conservative motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76).

In one embodiment the DNase to be added in the cleaning composition of the invention is a polypeptide of the NAWK-clade having DNase activity, which are NUC1 and NUC1A DNases, wherein the polypeptide comprises one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO:

75) or NPQL (SEQ ID NO: 76) and wherein the polypeptide is selected from the group consisting of:

a) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26,

b) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27,

c) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28,

d) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29,

e) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30,

f) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 ,

g) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32,

h) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33,

i) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34,

j) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35,

k) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36,

L) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and

m) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38.

Polypeptides having DNase activity and which comprise the NAWK-clade motifs have shown particularly good cleaning properties, e.g. the DNases are particularly effective in removing or reducing components of organic matter, such as biofilm associated DNA, from an item such as a textile or a hard surface.

In one embodiment the DNases to be added in a composition of the invention preferably belong to the group of DNases comprised in the KNAW-clade, which are NUC1 and NUC1_A DNases further comprising the conservative motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78).

In one embodiment the DNase to be added in the cleaning composition of the invention is a polypeptide of the KNAW clade having DNase activity, which are NUC1 and NUC1_A DNases, wherein the polypeptide comprises one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78), and wherein the polypeptide is selected from the group consisting of:

a) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39,

b) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40,

c) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 ,

d) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42,

e) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43

f) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44,

g) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45,

h) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46,

i) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47,

j) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48,

k) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49,

L) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and

m) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 .

Polypeptides having DNase activity and which comprise the KNAW-clade motifs have shown particularly good cleaning properties, e.g. the DNases are particularly effective in removing or reducing components of organic matter, such as biofilm associated DNA, from an item such as a textile or a hard surface.

In one embodiment the DNase to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus sp.and having a sequence identity to the polypeptide shown in SEQ ID NO: 1 of at least 60%, e.g., at least 65%, at least

70%, at least 75%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least

85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least

92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 1.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus horikoshii and having a sequence identity to the polypeptide shown in SEQ ID NO: 2 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 2.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 3 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 3.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 4 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 4.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus horikoshii and having a sequence identity to the polypeptide shown in SEQ ID NO: 5 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 5.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus horikoshii and having a sequence identity to the polypeptide shown in SEQ ID NO: 6 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 6.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 7 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 7.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 8 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 8.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 9 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 9.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 10 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 10.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus horneckiae and having a sequence identity to the polypeptide shown in SEQ ID NO: 1 1 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 1 1 .

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 12 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 12.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus cibi and having a sequence identity to the polypeptide shown in SEQ ID NO: 13 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 13.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 14 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 14.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus idriensis and having a sequence identity to the polypeptide shown in SEQ ID NO: 15 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 15.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus algicola having a sequence identity to the polypeptide shown in SEQ ID NO: 16 of at least 60%, e.g., at least 65%, at least

70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least

97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 16.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide having a sequence identity to the polypeptide shown in SEQ ID NO: 17 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 17.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus vietnamensis and having a sequence identity to the polypeptide shown in SEQ ID NO: 18 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 18.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus hwajinpoensis and having a sequence identity to the polypeptide shown in SEQ ID NO: 19 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 19.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Paenibacillus mucilaginosus and having a sequence identity to the polypeptide shown in SEQ ID NO: 20 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 20.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus indicus and having a sequence identity to the polypeptide shown in SEQ ID NO: 21 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 21 .

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus marisflavi and having a sequence identity to the polypeptide shown in SEQ ID NO: 22 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 22.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus luciferensis and having a sequence identity to the polypeptide shown in SEQ ID NO: 23 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 23.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus marisflavi and having a sequence identity to the polypeptide shown in SEQ ID NO: 24 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 24.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus sp. SA2-6 and having a sequence identity to the polypeptide shown in SEQ ID NO: 25 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 25.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Pyrenochaetopsis sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 26 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 26.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Vibrissea flavovirens and having a sequence identity to the polypeptide shown in SEQ ID NO: 27 of at least 60%, e.g., at least 65%, at least 70%, at least

75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least

98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 27.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Setosphaeria rostrate and having a sequence identity to the polypeptide shown in SEQ ID NO: 28 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 28.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Endophragmiella valdina and having a sequence identity to the polypeptide shown in SEQ ID NO: 29 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 29.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from C orynespora cassiicola and having a sequence identity to the polypeptide shown in SEQ ID NO: 30 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 30.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Paraphoma sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 31 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least

80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least

99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 31 .

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Monilinia fructicola and having a sequence identity to the polypeptide shown in SEQ ID NO: 32 of at least 60%, e.g., at least 65%, at least 70%, at least

98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 32.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Curvularia lunata and having a sequence identity to the polypeptide shown in SEQ ID NO: 33 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 33.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Penicillium reticulisporum and having a sequence identity to the polypeptide shown in SEQ ID NO: 34 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 34.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Penicillium quercetorum and having a sequence identity to the polypeptide shown in SEQ ID NO: 35 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 35.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Setophaeosphaeria sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 36 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 36.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Alternaria sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 37 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 37.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Alternaria and having a sequence identity to the polypeptide shown in SEQ ID NO: 38 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 38.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Trichoderma reesei and having a sequence identity to the polypeptide shown in SEQ ID NO: 39 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 39.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Chaetomium thermophilum and having a sequence identity to the polypeptide shown in SEQ ID NO: 40 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 40.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Scytalidium thermophilum and having a sequence identity to the polypeptide shown in SEQ ID NO: 41 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 41 .

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Metapochonia suchlasporia and having a sequence identity to the polypeptide shown in SEQ ID NO: 42 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 42.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Daldinia fissa and having a sequence identity to the polypeptide shown in SEQ ID NO: 43 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 43.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Acremonium sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 44 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 44.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Acremonium dichromosporum and having a sequence identity to the polypeptide shown in SEQ ID NO: 45 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 45.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Sarocladium sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 46 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 46.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Metarhizium sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 47 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 47.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Acremonium sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 48 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 48.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Isaria tenuipes and having a sequence identity to the polypeptide shown in SEQ ID NO: 49 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least

80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 49.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Scytalidium circinatum and having a sequence identity to the polypeptide shown in SEQ ID NO: 50 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 50.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Metarhizium lepidiotae and having a sequence identity to the polypeptide shown in SEQ ID NO: 51 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 51 .

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Thermobispora bispora and having a sequence identity to the polypeptide shown in SEQ ID NO: 52 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 52.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Sporormia fimetaria and having a sequence identity to the polypeptide shown in SEQ ID NO: 53 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 53.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Pycnidiophora cf. dispera and having a sequence identity to the polypeptide shown in SEQ ID NO: 54 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 54. In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide having a sequence identity to the polypeptide shown in SEQ ID NO: 55 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 55.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide having a sequence identity to the polypeptide shown in SEQ ID NO: 56 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 56.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Clavicipitaceae sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 57 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 57.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Westerdykella sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 58 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 58.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Humicolopsis cephalosporioides and having a sequence identity to the polypeptide shown in SEQ ID NO: 59 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 59.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Neosartorya massa and having a sequence identity to the polypeptide shown in SEQ ID NO: 60 of at least 60%, e.g., at least 65%, at least 70%, at least

98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 60.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Roussoella intermedia and having a sequence identity to the polypeptide shown in SEQ ID NO: 61 of at least 60%, e.g., at least 65%, at least 70%, at least

98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 61 .

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Pleosporales and having a sequence identity to the polypeptide shown in SEQ ID NO: 62 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least

99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 62.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Phaeosphaeria and having a sequence identity to the polypeptide shown in SEQ ID NO: 63 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least

99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 63.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Didymosphaeria futilis and having a sequence identity to the polypeptide shown in SEQ ID NO: 64 of at least 60%, e.g., at least 65%, at least 70%, at least

98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 64.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus licheniformis having a sequence identity to the polypeptide shown in SEQ ID NO: 65 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 65.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Bacillus, e.g. obtainable from Bacillus subtilis having a sequence identity to the polypeptide shown in SEQ ID NO: 66 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 66.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Aspergillus, e.g. obtainable from Aspergillus oryzae having a sequence identity to the polypeptide shown in SEQ ID NO: 67 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 67.

In one embodiment the DNases to be added in the cleaning composition of the invention is a polypeptide obtainable from Trichoderma, e.g. obtainable from Trichoderma harzianum having a sequence identity to the polypeptide shown in SEQ ID NO: 68 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have DNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 68.

The preparation of the polypeptide having DNase activity as described under this section be performed as described in the Nucleic acid Construct, Expression Vectors, Host Cells, Methods of Production and Fermentation Broth Formulations sections in WO 2017/059802 (Novozymes A/S).

The DNase can be included in the cleaning composition of the present invention at a level of from 0.01 to 1000ppm, from 1 ppm to 1000 ppm, from 10 ppm to 1000 ppm, from 50 ppm to 1000 ppm, from 100 ppm to 1000 ppm, from 150 ppm to 1000 ppm, from 200 ppm to 1000 ppm_s from 250 ppm to 1000 ppm, from 250 ppm to 750 ppm, or from 250 ppm to 500 ppm.

The DNases above may be combined with hexosaminidase to form a blend to be added to the wash liquor solution according to the invention. The concentration of the DNase in the wash liquor solution is typically in the range of wash liquor from 0.00001 ppm to 10 ppm, from 0.00002 ppm to 10 ppm, from 0.0001 ppm to 10 ppm, from 0.0002 ppm to 10 ppm, from 0.001 ppm to 10 ppm_s from 0.002 ppm to 10 ppm, from 0.01 ppm to 10 ppm, from 0.02 ppm to 10 ppm, 0.1 ppm to 10 ppm, from 0.2ppm to 10 ppm, or from 0.5 ppm to 5 ppm.

The DNases may be combined with any of the hexosaminidases below to form a blend to be added to a composition according to the invention. Polypeptides having Hexosaminidase activity (hexosaminidases)

The term hexosaminidase includes“dispersin’’ and the abbreviation“Dsp”, which means a polypeptide having hexosaminidase activity, EC 3.2.1 .- that catalyzes the hydrolysis of b-1 ,6- glycosidic linkages of N-acetyl-glucosamine polymers found e.g. in biofilm. The term hexosaminidase includes polypeptides having N-acetylglucosaminidase activity and b-N- acetylglucosaminidase activity. The term“polypeptide having hexosaminidase activity” may be used interchangeably with the term hexosaminidases and similarly the term“polypeptide having b-N-acetylglucosaminidase activity” may be used interchangeably with the term b-N- acetylglucosaminidases. For purposes of the present invention, hexosaminidase activity is determined according to the procedure described in Assay II. In a preferred embodiment, the polypeptide having hexosaminidase activity is a dispersin. In a preferred embodiment, the polypeptide having hexosaminidase activity is a b-N-acetylglucosaminidase targeting poly-b-1 ,6- N-acetylglucosamine.

In one embodiment, the invention relates to a composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a cleaning component.

One embodiment of the invention relates to a composition comprising a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, polypeptide wherein the polypeptide is selected from the group consisting of:

a) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 82,

b) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 83,

c) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 84,

d) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 85,

e) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 86,

f) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 87, g) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 88,

h) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 89,

i) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 90,

j) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 91 ,

k) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 92,

L) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 93,

m) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 94,

n) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 95,

o) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 96,

p) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 97,

q) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 98, and

r) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 99,

and wherein the polypeptide cleaves b-substituted N-acetyl glucosamide.

A polypeptide having hexosaminidase activity may be obtained from microorganisms of any genus. Preferably the hexosaminidase or the b-N-acetylglucosaminidase targeting poly-b-1 ,6- N-acetylglucosamine e.g. a dispersin is obtained from Terribacillus, Curtobacterium, Aggregatibacter, Haemophilus or Actinobacillus, preferably Terribacillus.

In one aspect, the polypeptide having hexosaminidase activity is a Terribacillus polypeptide, e.g., a polypeptide obtained from Terribacillus saccharophilus. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to

SEQ ID NO: 82 and is obtained from Terribacillus, preferably Terribacillus saccharophilus.

In another aspect, the polypeptide is a Terribacillus polypeptide, e.g., a polypeptide obtained from Terribacillus goriensis. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 83 and is obtained from Terribacillus, preferably Terribacillus goriensis.

In another aspect, the polypeptide is a Terribacillus polypeptide, e.g., a polypeptide obtained from Terribacillus saccharophilus. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 84 and is obtained from Terribacillus, preferably Terribacillus saccharophilus.

In another aspect, the polypeptide is a Terribacillus polypeptide, e.g., a polypeptide obtained from Terribacillus saccharophilus. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 98 and is obtained from Terribacillus, preferably Terribacillus saccharophilus.

In another aspect, the polypeptide is a Terribacillus polypeptide, e.g., a polypeptide obtained from Terribacillus saccharophilus. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 99 and is obtained from Terribacillus, preferably Terribacillus saccharophilus.

In another aspect, the polypeptide is a Curtobacterium polypeptide, e.g., a polypeptide obtained from Curtobacterium oceanosedimentum. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least

85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least

96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 85 and is obtained from Curtobacterium,, preferably Curtobacterium oceanosedimentum.

In another aspect, the polypeptide is a Curtobacterium polypeptide, e.g., a polypeptide obtained from Curtobacterium flaccumfaciens. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 94 and is obtained from Curtobacterium preferably Curtobacterium flaccumfaciens.

In another aspect, the polypeptide is a Curtobacterium polypeptide, e.g., a polypeptide obtained from Curtobacterium luteum. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 95 and is obtained from Curtobacterium, preferably Curtobacterium luteum.

In another aspect, the polypeptide is a Curtobacterium polypeptide, e.g., a polypeptide obtained from Curtobacterium oceanosedimentum. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 96 and is obtained from Curtobacterium, preferably Curtobacterium oceanosedimentum.

In another aspect, the polypeptide is a Curtobacterium polypeptide, e.g., a polypeptide obtained from Curtobacterium Ieaf154. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 97 and is obtained from Curtobacterium, preferably Curtobacterium leafl 54.

In another aspect, the polypeptide is an Aggregatibacter polypeptide, e.g., a polypeptide obtained from Aggregatibacter actinomycetemcomitans. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO:

86 and is obtained from Aggregatibacter, preferably Aggregatibacter actinomycetemcomitans.

In another aspect, the polypeptide is a Haemophilus polypeptide, e.g., a polypeptide obtained from Haemophilus sputorum. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 87 and is obtained from Haemophilus, preferably Haemophilus sputorum.

In another aspect, the polypeptide is an Actinobacillus polypeptide, e.g., a polypeptide obtained from Actinobacillus suis. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 88 and is obtained from Actinobacillus, preferably Actinobacillus suis.

In another aspect, the polypeptide is an Actinobacillus polypeptide, e.g., a polypeptide obtained from Actinobacillus capsulatus DSM 19761. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least

96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 89 and is obtained from Actinobacillus, preferably Actinobacillus capsulatus DSM 19761.

In another aspect, the polypeptide is an Actinobacillus polypeptide, e.g., a polypeptide obtained from Actinobacillus equuli subsp. equuli. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least

96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 90 and is obtained from Actinobacillus, preferably Actinobacillus equuli subsp. equuli.

91 and is obtained from Aggregatibacter, preferably Aggregatibacter actinomycetemcomitans.

92 and is obtained from Aggregatibacter, preferably Aggregatibacter actinomycetemcomitans.

In another aspect, the polypeptide is an Actinobacillus polypeptide, e.g., a polypeptide obtained from Actinobacillus pleuropneumoniae. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least

96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 93 and is obtained from Actinobacillus, preferably Actinobacillus pleuropneumoniae.

In another aspect, the polypeptide is a Curtobacterium polypeptide, e.g., a polypeptide obtained from Curtobacterium flaccumfaciens. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 94 and is obtained from Curtobacterium, preferably Curtobacterium flaccumfaciens

In another aspect, the polypeptide is a Curtobacterium polypeptide, e.g., a polypeptide obtained from Curtobacterium Leaf154. In a preferred aspect, the polypeptide is a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to SEQ ID NO: 97 and is obtained from Curtobacterium, preferably Curtobacterium Leaf 154.

Polypeptides of this type which are useful in the present invention belong to the Glycoside Hydrolase family 20 (GH20, www.cazy.org). This family includes dispersins such as Dispersin B (DspB) which is b-N-acetylglucosaminidases belonging to the Glycoside Hydrolase 20 family.

The preparation of the polypeptide having hexosaminidase activity as described under this section may be prepared as described in the Nucleic acid Construct, Expression Vectors, Host Cells, Methods of Production and Fermentation Broth Formulations sections in WO 2017/059802 (Novozymes A/S).

The hexosaminidase can be included in the cleaning composition of the present invention at a level of from 0.01 to 1000 ppm, from 1 ppm to 1000 ppm, from 10 ppm to 1000 ppm, from 50 ppm to 1000 ppm, from 100 ppm to 1000 ppm, from 150 ppm to 1000 ppm, from 200 ppm to 1000 ppm, from 250 ppm to 1000 ppm, from 250 ppm to 750 ppm, or from 250 ppm to 500 ppm.

The hexosaminidase can be included in the wash liquor solution of the present invention at a level of from 0.00001 ppm to 10 ppm, from 0.00002 ppm to 10 ppm, from 0.0001 ppm to 10 ppm, from 0.0002 ppm to 10 ppm, from 0.001 ppm to 10 ppm, from 0.002 ppm to 10 ppm, from 0.01 ppm to 10 ppm, from 0.02 ppm to 10 ppm, from 0.1 ppm to 10 ppm, from 0.2 ppm to 10 ppm, or from 0.5 ppm to 5 ppm.

Polypeptides classified as Glvco hydro 1 14 qlvcosyl hydrolases

Glycosyl hydrolases classified as Glyco_hydro_1 14 hydrolases and comprised in a composition according to the invention are classified as a Glyco_hydro_1 14 hydrolases according to the classification in (Pfam domain id PF03537, Pfam version 31 .0 Finn (2016). Nucleic Acids Research, Database Issue 44:D279-D285). These polypeptides of the invention may further comprise a polysaccharide deacetylase domain (CE4) and in a preferred embodiment they have hydrolytic and/or deacetylase activity. Polypeptides according to the invention having hydrolytic and/or deacetylase activity include Glyco_hydro_1 14 glycosyl hydrolases. A Glyco_hydro_1 14 glycosyl hydrolase is in the context of the present invention a glycosyl hydrolase comprising glycosyl hydrolase domain (DUF297), which here is termed Glyco_hydro_1 14 (Pfam domain id PF03537, Pfam version 31 .0 Finn (2016). In one preferred embodiment, the polypeptides of the invention are endo-alpha-1 ,4-polygalactosaminidases, and in one embodiment the polypeptides of the invention are endo-alpha-l,4-polygalactosminidase belonging to class (EC 3.2.1.109). Thus, the enzymes of the invention preferably have endo- alpha-l,4-polygalactosaminidase activity. The polypeptides of the invention have at least hydrolytic activity to a glyosidic bond and may also have deacetylase activity. In the context of the present invention the Glyco_hydro_1 14 glycosyl hydrolase is a PelA enzyme, which is active towards the polysaccharide pel, present in many biofilms. The pellicle (pel) polysaccharide is synthesized e.g. by Pseudomonas aeruginosa and is an important biofilm constituent critical for bacterial virulence and persistence. Pel is a cationic polymer composed of partially acetylated 1 4 glycosidic linkages of N-acetylgalactosamine and N-acetylglucosamine that promotes cell- cell interactions within the biofilm matrix through electrostatic interactions with extracellular DNA (Jennings et al. PNAS Sept 2015, vol.1 12, no36, 1 1353-1 1358; Marmont et.al. J Biol Chem. 2017 Nov 24;292(47):1941 1 -19422. 2017). The glycosyl hydrolases to be incorporated with a dispersin in a composition according to the invention preferably belong to the Glyco_hydro_1 14 pFam domain (PF03537) family. They preferably comprise a domain termed herein as the CE4_PelA_like domain, which polypeptides are represented by a protein PelA that is encoded by a gene in the pelA-G gene cluster for pellicle production and biofilm formation in Pseudomonas aeruginosa. PelA and most of the family members contain a domain of unknown function, DUF297 (PF03537). The glycosyl hyrdrolases are preferably PelA homologues.

The glycosyl hydrolase may be obtainable from Pseudomonas protegenes Pf-5, Pseudomonas aeruginosa or Geobacter metallireducens. Preferably the glycosyl hydrolases to be combined with a dispersin of the invention are any of those shown inTable 1 .

Table 1

In one embodiment the invention relates to a composition comprising a dispersin and a glycosyl hydrolase, wherein the glycosyl hydrolase is glycosyl hydrolase comprising a Glyco_hydro_1 14 domain, and a cleaning component

The glycosyl hydrolases to be combined with a dispersin in a composition according to the invention comprise a GH domain which may be classified as a Glyco_hydro_1 14 domain and in a preferred embodiment the polypeptides have hydrolytic (EC 3.2.1.) activity (http://www.cazy.orq/). The polypeptides comprising the Glyco_hydro_1 14 domain are preferably homologues of PelA enzymes, which are proteins that degrade the exopolysaccharide Pel. In one embodiment, the glycosyl hydrolase is a glycosyl hydrolase comprising the domain Glyco_hydro_1 14 glycosyl preferably obtained from Pseudomonas such as Pseudomonas sp., Pseudomonas seleniipraecipitans, Pseudomonas migulae, Pseudomonas corrugate, Pseudomonas pelagia, Pseudomonas aeruginosa, or Pseudomonas composti. In another embodiment the Glyco_hydro_1 14 glycosyl hydrolase is preferably obtained from Myxococcus such as Myxococcus macrosporus, Myxococcus virescens, Myxococcus fulvus Myxococcus stipitatus. The Glyco_hydro_1 14 glycosyl hydrolase may also be obtained from any of the following organisms: Thermus rehai, Burkholderia sp., Gallaecimonas pentaromativorans, Nonomuraea coxensis, Glycomyces rutgersensis, Paraburkholderia phenazinium, Streptomyces griseofuscus, Lysinibacillus xylanilyticus, Tumebacillus ginsengisoli, Lysinibacillus boronitolerans, Microbulbifer hydrolyticus, or Carnobacterium inhibens subsp.

In one embodiment, the invention relates to a composition comprising a dispersin, a glycosyl hydrolase, wherein the glycosyl hydrolase comprises the Glyco_hydro_1 14 glycosyl hydrolase domain, and a cleaning component.

The glycosyl hydrolases preferably comprise one or more or both the motif(s) GX[FY][LYF]D (SEQ ID NO 132) or AYX[SET]XX[EAS] (SEQ ID NO 133). One embodiment of the invention relates to a composition comprising a polypeptide having glycosyl hydrolase activity, optionally wherein the polypeptide optionally comprises one or both the motifs GX[FY][LYF]D (SEQ ID NO 132) or AYX[SET]XX[EAS] (SEQ ID NO 133) and wherein the polypeptide is selected from the group consisting of:

a) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 100,

b) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 101 ,

c) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 102,

d) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 103,

e) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 104,

f) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 105,

g) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 106,

h) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 107,

i) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 108,

j) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 109,

k) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 10,

L) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 1 1 ,

m) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 12,

n) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 13,

o) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 14,

p) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 15,

q) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 16,

r) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 17,

s) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 18,

t) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 19,

u) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 120,

v) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 121 ,

w) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 122,

x) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 123, y) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 124,

z) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 125,

aa) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 126,

bb) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 127,

cc) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 128,

dd) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 129,

ee) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 130, and

ft) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 131.

In some preferred embodiments of the invention a dispersin of the invention is combined with a glycosyl hydrolase, wherein the glycosyl hydrolase is any of the following:

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Pseudomonas sp. and having a sequence identity to the polypeptide shown in SEQ ID NO 100 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 100.

In some embodiments, the present invention relates to compositions comprising a polypeptide having a sequence identity to the polypeptide shown in SEQ ID NO 101 of at least

60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 101 .

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Thermus rehai and having a sequence identity to the polypeptide shown in SEQ ID NO 102 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 102.

In some embodiments, the present invention relates to compositions comprising a polypeptide having a sequence identity to the polypeptide shown in SEQ ID NO 103 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 103.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Burkholderia sp. and having a sequence identity to the polypeptide shown in SEQ ID NO 104 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 104.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Myxococcus macrosporus and having a sequence identity to the polypeptide shown in SEQ ID NO 105 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 105.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Gallaecimonas pentaromativorans and having a sequence identity to the polypeptide shown in SEQ ID NO 106 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 106.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Nonomuraea coxensis and having a sequence identity to the polypeptide shown in SEQ ID NO 107 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 107.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Glycomyces rutgersensis and having a sequence identity to the polypeptide shown in SEQ ID NO 108 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 108.

In some embodiments, the present invention relates to compositions comprising a polypeptide having a sequence identity to the polypeptide shown in SEQ ID NO 109 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 109.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Paraburkholderia phenazinium and having a sequence identity to the polypeptide shown in SEQ ID NO 1 10 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 1 10.

In some embodiments, the present invention relates to compositions comprising a polypeptide having a sequence identity to the polypeptide shown in SEQ ID NO 1 1 1 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 1 1 1.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Myxococcus virescens and having a sequence identity to the polypeptide shown in SEQ ID NO 1 12 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 1 12.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Myxococcus fulvus and having a sequence identity to the polypeptide shown in SEQ ID NO 1 13 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 1 13.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Myxococcus macrosporus and having a sequence identity to the polypeptide shown in SEQ ID NO 1 14 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 1 14.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Myxococcus stipitatus and having a sequence identity to the polypeptide shown in SEQ ID NO 1 15 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 1 15.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Myxococcus macrosporus and having a sequence identity to the polypeptide shown in SEQ ID NO 1 16 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 1 16.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Pseudomonas seleniipraecipitans and having a sequence identity to the polypeptide shown in SEQ ID NO 1 17 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 1 17.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Pseudomonas migulae and having a sequence identity to the polypeptide shown in SEQ ID NO 1 18 of at least 60%, e.g., at least 65%, at least 70%, at least

75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 1 18.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Pseudomonas corrugate and having a sequence identity to the polypeptide shown in SEQ ID NO 1 19 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 119.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Pseudomonas pelagia and having a sequence identity to the polypeptide shown in SEQ ID NO 120 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 120.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Pseudomonas aeruginosa and having a sequence identity to the polypeptide shown in SEQ ID NO 121 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 121.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Streptomyces griseofuscus and having a sequence identity to the polypeptide shown in SEQ ID NO 122 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 122.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Lysinibacillus xylanilyticus and having a sequence identity to the polypeptide shown in SEQ ID NO 123 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 123. In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Tumebacillus ginsengisoli and having a sequence identity to the polypeptide shown in SEQ ID NO 124 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 124.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Lysinibacillus boron itolerans and having a sequence identity to the polypeptide shown in SEQ ID NO 125 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 125.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Microbulbifer hydrolyticus and having a sequence identity to the polypeptide shown in SEQ ID NO 126 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 126.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Carnobacterium inhibens subsp. and having a sequence identity to the polypeptide shown in SEQ ID NO 127 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 127.

In some embodiments, the present invention relates to compositions comprising a polypeptide having a sequence identity to the polypeptide shown in SEQ ID NO 128 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 128.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Pseudomonas composti and having a sequence identity to the polypeptide shown in SEQ ID NO 129 of at least 60%, e.g., at least 65%, at least 70%, at least

75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 129.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Paraburkholderia phenazinium and having a sequence identity to the polypeptide shown in SEQ ID NO 130 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 130.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Burkholderia sp. and having a sequence identity to the polypeptide shown in SEQ ID NO 131 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have glycosyl hydrolase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO 131.

Polypeptides having RNase activity (RNase)

The term“RNase” is an abbreviation of the term ribonuclease, which means a nuclease having RNase activity (EC 3.1 .2.7) that catalyzes the degradation of RNA into smaller components. Ribonucleases can be divided into endoribonucleases and exoribonucleases. In one embodiment, the present invention relates to e.g. endoribonucleases. For purposes of the present invention, RNase activity is determined according to the procedure described in Assay V. Preferably the RNase to be incorporated in a composition of the invention includes RNases from the PF00545 family of RNases e.g. the RNase Barnase, Swiss Prot P00648 (SEQ ID NO 91 ) or closely related homologues having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the amino acid sequence shown in SEQ ID 143.

In one embodiment, the RNases to be added to a composition of the invention are selected from RNases with E.C.3.1.26.X, where X = 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12 or 13, e.g. the RNases Physarum polycephalum RNase, RNase alpha, RNase III, RNase C, RNase H, RNase Hll, RNase P, RNase IV, RNase P4, RNase M5, RNase poly-U specific, RNase IX, RNase Z, RNase E, RNase L or Retroviral RNase H. The RNase may also be selected from EC.3.1 .27. Y, where Y= 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, e.g. the RNases; RNase T(2), Bacillus subtilis RNase, RNase T(1 ), RNase U(2), Pancreatic RNase, RNase A, RNase I, Enterobacter RNase, RNase F, RNase V, rRNA endonuclease and e.g. RNase B Glycoprotein standard from bovine pancreas. In one embodiment, the RNase is any of the following: RNase A (Bovine pancreas) UniProt - P61823, RNase HI (E. coli) Uniprot- P0A7Y4, RNase Hll (E. coli) UniProt - P10442, RNase III (E. coli) UniProt - P0A7Y0, RNase T1 (A. oryzae) UniProt - P00651 , RNase T2 (A. oryzae) Uniprot - P10281 or closely related homologues e.g. RNase having at least 80%, or at least 85% or at least 90% or at least 95% or at least 98% sequence identity hereto.

The RNase may be obtainable from Paenibacillus e.g. Paenibacillus sp., orPaenibacillus tundrae. Alternatively, the RNase may be obtained from e.g. Amycolatopsis azurea, Acremonium alcalophilum, Erwinia persicina, Saccharothrix sp., Saccharopolyspora endophytica, Amycolatopsis circi, Alkalimonas sp., or Nonomuraea dietziae.

In a preferred embodiment, the RNase comprises any one or more of the following or all of the motifs EYTV (SEQ ID NO 134), [YRF]E[AYFWC]D (SEQ ID NO 135), IGGD (SEQ ID NO 136), YPH, HTGA (SEQ ID NO 137) or DRV.

One embodiment of the invention relates to a composition comprising a polypeptide having RNase activity, optionally wherein the polypeptide comprises one or more or all the motifs EYTV (SEQ ID NO 134, [YRF]E[AYFWC]D (SEQ ID NO 135), IGGD (SEQ ID NO 136), YPH, HTGA (SEQ ID NO 137) or DRV and wherein the polypeptide is selected from the group consisting of: a) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 138,

b) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 139,

c) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 140,

d) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 141 ,

e) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 142,

f) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 143,

g) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 144,

h) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 145,

i) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 146,

j) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 147,

k) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 148,

L) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 149,

m) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 150,

n) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 151 ,

o) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 152,

p) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 153,

q) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 154,

r) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 155, and

s) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 156.

In some preferred embodiments of the invention a DNase of the invention is combined with an RNase, wherein the RNase is any of the following:

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Paenibacillus sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 138 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 138.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Paenibacillus sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 139 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 139.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Amycolatopsis azurea and having a sequence identity to the polypeptide shown in SEQ ID NO: 140 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 140.

In some embodiments, the present invention relates to compositions comprising a polypeptide having a sequence identity to the polypeptide shown in SEQ ID NO: 141 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 141.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Acremonium alcalophilum and having a sequence identity to the polypeptide shown in SEQ ID NO: 142 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 142.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Bacillus amyloliquefaciens and having a sequence identity to the polypeptide shown in SEQ ID NO: 143 of at least 60%, e.g., at least 65%, at least 70%, at least

98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 143.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Stenotrophomonas rhizophila and having a sequence identity to the polypeptide shown in SEQ ID NO: 144 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 144.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Erwinia persicina and having a sequence identity to the polypeptide shown in SEQ ID NO: 145 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 145.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Paenibacillus tundrae and having a sequence identity to the polypeptide shown in SEQ ID NO: 146 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 146.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Saccharothrix sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 147 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 147.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Saccharopolyspora endophytica and having a sequence identity to the polypeptide shown in SEQ ID NO: 148 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 148.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Amycolatopsis circi and having a sequence identity to the polypeptide shown in SEQ ID NO: 149 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 149.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Paenibacillus sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 150 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 150.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Paenibacillus sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 151 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 151 .

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Paenibacillus sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 152 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 152.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Alkalimonas sp. and having a sequence identity to the polypeptide shown in SEQ ID NO: 153 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 153.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Nonomuraea dietziae and having a sequence identity to the polypeptide shown in SEQ ID NO: 154 of at least 60%, e.g., at least 65%, at least 70%, at least

75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 154.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Trichoderma harzianum and having a sequence identity to the polypeptide shown in SEQ ID NO: 155 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 155.

In some embodiments, the present invention relates to compositions comprising a polypeptide obtainable from Fusarium solani and having a sequence identity to the polypeptide shown in SEQ ID NO: 156 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which have RNase activity. In one aspect, the polypeptides differ by up to 10 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10, from the mature polypeptide shown in SEQ ID NO: 156.

Cleaning composition

The invention relates to cleaning compositions comprising at least one DNase, at least one hexosaminidase and at least one glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase in combination with one or more additional cleaning components. The choice of additional components is within the skill of the artisan and includes conventional ingredients, including the exemplary non-limiting components set forth below. An enzyme blend of the current invention comprises e.g. a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin and a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase. One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase and a cleaning component.

The DNase is preferably microbial, preferably obtained from bacteria or fungi. One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase and a cleaning component, wherein the DNase is microbial preferably bacteria or fungi.

In one embodiment, the DNase is obtained from bacteria. One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin, glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis.

The hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is preferably selected from the genus Terribacillus, preferably Terribacillus goriensis or Terribacillus saccharophilus. Alternatively, the hexosaminidase may be obtained from the genus Curtobacterium, preferably Curtobacterium oceanosedimentum, Curtobacterium flaccumfaciens, Curtobacterium luteus or Curtobacterium leaf 154. Alternatively, the hexosaminidase may be obtained from the genus Aggregatibacter, preferably Aggregatibacter actinomycetemcomitans. Alternatively, the hexosaminidase may be obtained from genus Haemophilus, preferably Haemophilus sputorum. Alternatively, the hexosaminidase may be obtained from the genus Actinobacillus preferably Actinobacillus suis, Actinobacillus capsulatus DSM 19761, Actinobacillus equuli subsp. Equuli or Actinobacillus pleuropneumoniae.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is obtained from Terribacillus such as Terribacillus goriensis or Terribacillus saccharophilus.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is obtained from Curtobacterium such as Curtobacterium oceanosedimentum, Curtobacterium flaccumfaciens, Curtobacterium luteus or Curtobacterium leaf 154.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is obtained from

Aggregatibacter such as Aggregatibacter actinomycetemcomitans. One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is obtained from Haemophilus such as Haemophilus sputorum.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is obtained from Actinobacillus such as Actinobacillus suis, Actinobacillus capsulatus DSM 19761, Actinobacillus equuli subsp. Equuli or Actinobacillus pleuropneumoniae.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is selected from the group consisting of;

f) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 87,

g) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 88,

q) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 98, and r) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 99.

The DNases preferably belong to the NUC1 group of DNases and comprise one or more of the motifs [T/D/S][G/N]PQL (SEQ ID NO 69), [F/L/Y/I]A[N/R]D[L/I/P/V] (SEQ ID NO: 70), or C[D/N]T[A/R] (SEQ ID NO: 71 ). The DNases even more preferably comprise a NUC1_A domain [D/Q][I/V]DH (SEQ ID NO 72), in addition to comprising any of the domain motifs [T/D/S][G/N]PQL, [F/L/Y/I]A[N/R]D[L/I/P/V] or C[D/N]T[A/R] The DNases to be added to a composition of the invention preferably belong to the group of DNases comprised in the GYS- clade, which are group of DNases on the same branch of a phylogenetic tree having both structural and functional similarities. These NUC1 and/or NUC1_A DNases comprise the conservative motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) and share similar structural and functional properties. The DNases of the GYS-clade are preferably obtained from Bacillus genus. One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase comprises one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74). One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase comprises one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74), wherein the hexosaminidase is selected from the group consisting of;

e) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 86, f) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 87,

r) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 99.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase comprises one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) and wherein the DNase is selected from the group consisting of:

a) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 1 ,

b) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 2,

c) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 3,

d) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 4,

e) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 5,

f) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 6,

g) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 7,

h) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 8,

i) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 9,

j) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 10,

k) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 1 1 ,

L) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 12,

m) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 13,

n) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 14,

o) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 15,

p) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 16,

q) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 17,

r) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 18,

s) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 19,

t) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 20,

u) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 21 ,

v) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 22,

w) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 23,

x) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 24, and

y) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 25.

The DNase is preferably a bacillus DNase, such as a Bacillus cibi, Bacillus subtilis or Bacillus licheniformis.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 13.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO: 65.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO: 66.

The DNase may also be fungal. One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase is fungal, preferably obtained from Aspergillus and even more preferably from Aspergillus oryzae and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or

100% sequence identity to the amino acid sequence shown in SEQ ID NO: 67.

One embodiment relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase and a cleaning component, wherein the DNase is fungal, preferably obtained from Trichoderma and even more preferably from Trichoderma harzianum and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO: 68.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 13 and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is selected from the group consisting of hexosaminidases comprising an amino acid sequence with;

i) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 82,

ii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 83,

iii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 84,

iv) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 85,

v) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 86,

vi) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 87,

vii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 88,

viii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 89,

ix) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 90,

x) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 91 ,

xi) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 92,

xii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 93,

xiii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 94,

xiv) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 95,

xv) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 96,

xvi) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 97,

xvii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 98, and

xviii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 99.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 65 and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is selected from the group consisting of hexosaminidases comprising an amino acid sequence with;

i) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 82

ii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 83

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 66 and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is selected from the group consisting of hexosaminidases comprising an amino acid sequence with;

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 67 and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is selected from the group consisting of hexosaminidases comprising an amino acid sequence with;

xi) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 92, xii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 93,

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 68 and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is selected from the group consisting of hexosaminidases comprising an amino acid sequence with;

iii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 84, iv) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 85,

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase and a cleaning component wherein the a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase is selected among polypeptides having hydrolytic and/or deacetylase activity and comprising an amino acid sequence with:

a) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 100,

b) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 101 ,

c) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 102,

d) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 103,

e) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 104,

f) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 105,

g) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 106,

h) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 107,

i) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 108,

j) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 109,

k) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 10,

L) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 1 1 ,

m) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 12,

n) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 13,

o) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 14,

p) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 15,

q) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 16,

r) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 17,

s) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 18,

t) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 19,

u) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 120,

v) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 121 ,

w) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 122,

x) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 123,

y) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 124,

z) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 125,

aa) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 126,

bb) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 127,

cc) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 128,

dd) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 129,

ee) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 130, and

ft) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 131 .

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ

ID NO 13, and wherein the a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase is selected among polypeptides having hydrolytic and/or deacetylase activity and comprising an amino acid sequence with:

b) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 101 ,

c) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 102,

d) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 103,

e) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 104,

f) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 105,

g) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 106,

h) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 107,

at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 108,

j) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 109,

k) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 1 10,

I) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 1 1 1 , m) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 12,

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 65, and wherein the a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase is selected among polypeptides having hydrolytic and/or deacetylase activity and comprising an amino acid sequence with:

I) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 1 1 ,

bb) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 127, cc) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 128,

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 66, and wherein the a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase is selected among polypeptides having hydrolytic and/or deacetylase activity and comprising an amino acid sequence with:

f) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 105, g) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 106,

at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 17,

S) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 1 18,

t) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 1 19,

u) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 120,

v) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 121 ,

w) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 122,

x) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 123,

y) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 124,

z) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 125,

aa) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 126,

bb) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 127,

cc) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 128,

dd) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 129,

ee) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ D NO 130, and

ft) at least 60%, at least 65% at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 131 .

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 67, and wherein the a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase is selected among polypeptides having hydrolytic and/or deacetylase activity and comprising an amino acid sequence with:

v) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 121 , w) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 122,

ft) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 131.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 68, and wherein the a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase is selected among polypeptides having hydrolytic and/or deacetylase activity and comprising an amino acid sequence with: a) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 100,

One embodiment of the present invention relates to a cleaning composition comprising;

a) at least 0.01 ppm of at least one polypeptide having DNase activity, wherein the DNase is selected from the group consisting of:

i) a NUC1 or NUC1A DNase comprising one or more of the motifs [T/D/S][G/N]PQL (SEQ ID NO 69), [F/L/Y/I]A[N/R]D[L/I/P/V] (SEQ ID NO: 70), or C[D/N]T[A/R] (SEQ ID NO: 71 );

ii) a NUC1 or NUC1A DNase comprising the motif [D/Q][IA/]DH (SEQ ID NO 72);

iii) a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74); iv) a NUC1 or NUC1A DNase comprising one or both of the motifs [V/l ] P L[S/A] N AWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76);

v) a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO:78);

vi) a polypeptide having DNase activity selected from: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in

SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least

80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least

80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

15, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

19, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

51 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 52, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 53, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 54, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

55, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 56, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 57, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 58, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

59, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 60, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 61 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 62, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

63, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 64, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 65, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 66, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 67, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 68;

b) at least 0.01 ppm hexosaminidase selected from the group consisting of

I. a polypeptide having hexosaminidase activity selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 82, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 83, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 84, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 85, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 86, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 87, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 88, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 89, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 90, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 91 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 92, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 93; a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 94; a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 95; a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 96; a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 97; a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 98; a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 99;

II. a polypeptide having N-acetylglucosaminidase activity, preferably b-N- acetylglucosaminidase activity; and

III. a polypeptide comprising a GH20 domain.

c) at least 0.01 ppm of a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase and having hydrolytic and/or deacetylase activity, selected from the group of: a polypeptide having at least 80% sequence identity to SEQ ID NO: 100; a polypeptide having at least 80% sequence identity to SEQ ID NO: 101 ; a polypeptide having at least 80% sequence identity to SEQ ID NO: 102; a polypeptide having at least 80% sequence identity to SEQ ID NO: 103; a polypeptide having at least 80% sequence identity to SEQ ID NO: 104; a polypeptide having at least 80% sequence identity to SEQ ID NO: 105; a polypeptide having at least 80% sequence identity to SEQ ID NO: 106; a polypeptide having at least 80% sequence identity to SEQ ID NO: 107; a polypeptide having at least 80% sequence identity to SEQ ID NO: 108; a polypeptide having at least 80% sequence identity to SEQ ID NO: 109; a polypeptide having at least 80% sequence identity to SEQ ID NO: 1 10; a polypeptide having at least 80% sequence identity to SEQ ID NO: 1 1 1 ; a polypeptide having at least 80% sequence identity to SEQ ID NO: 1 12; a polypeptide having at least 80% sequence identity to SEQ ID NO: 1 13; a polypeptide having at least 80% sequence identity to SEQ ID NO: 1 14; a polypeptide having at least 80% sequence identity to SEQ ID NO: 1 15; a polypeptide having at least 80% sequence identity to SEQ ID NO: 1 16; a polypeptide having at least 80% sequence identity to SEQ ID NO: 1 17; a polypeptide having at least 80% sequence identity to SEQ ID NO: 1 18; a polypeptide having at least 80% sequence identity to SEQ ID NO: 1 19; a polypeptide having at least 80% sequence identity to SEQ ID NO: 120; a polypeptide having at least 80% sequence identity to SEQ ID NO: 121 ; a polypeptide having at least 80% sequence identity to SEQ ID NO: 122; a polypeptide having at least 80% sequence identity to SEQ ID NO: 123; a polypeptide having at least 80% sequence identity to SEQ ID NO: 124; a polypeptide having at least 80% sequence identity to SEQ ID NO: 125; a polypeptide having at least 80% sequence identity to SEQ ID NO: 126; a polypeptide having at least 80% sequence identity to SEQ ID NO: 127; a polypeptide having at least 80% sequence identity to SEQ ID NO: 128; a polypeptide having at least 80% sequence identity to SEQ ID NO: 129; a polypeptide having at least 80% sequence identity to SEQ ID NO: 130; and a polypeptide having at least 80% sequence identity to SEQ ID NO: 100. d) one or more cleaning components, e.g. one or more components selected from surfactants, builders, bleach components, polymers, dispersing agents and additional enzymes.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a

NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID

NO: 73) or ASXNRSKG (SEQ ID NO: 74), preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 82; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; and at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 83; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; and at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 84; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; and at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 85; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; and at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 86; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 87; and at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; and at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 88; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 89; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 90; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 91 ; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 92; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 93; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 94; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 95; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 96; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 97; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 98; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 99; at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

DNase sequence having at least 80% sequence identity to the polypeptide shown in SEQ ID NO:

13, and at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 84 or 98, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76), preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 82, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO:

75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 83, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 84, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 85, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 86, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 87, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 88, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 89, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 90, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 91 , at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 92, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 93, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 94, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 95, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 96, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 97, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 98, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 99, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 82, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or

[K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 83, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 84, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 85, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 86, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

[K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 87, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 88, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 89, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 90, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

[K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 91 , at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 92, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 93, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 94, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

[K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 95, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 96, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39 ,. a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40 ,. a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42. , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43 ,. a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44. , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45 ,. a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46 ,. a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47. , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48 ,. a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49 ,. a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 97, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 98, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 99, at least 10 ppm of glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

a) at least 0.01 ppm of a DNase selected from; a obtainable from Bacillus licheniformis having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 65, a DNase obtainable from Bacillus subtilis having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 66, a DNase obtainable from Aspergillus oryzae having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 67 or a DNase obtainable from Jrichoderma harzianum having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 68; and

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 82,

c) at least 0.01 ppm of a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase, and d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 83,

c) at least 0.01 ppm of a glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase, and d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 84,

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 85,

One preferred embodiment relates to a cleaning composition comprising; a) at least 0.01 ppm of a DNase selected from; a obtainable from Bacillus licheniformis having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 65, a DNase obtainable from Bacillus subtilis having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 66, a DNase obtainable from Aspergillus oryzae having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 67 or a DNase obtainable from Jrichoderma harzianum having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 68; and

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 86,

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 87,

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 88,

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 89,

One preferred embodiment relates to a cleaning composition comprising;

a) at least 0.01 ppm of a DNase selected from; a obtainable from Bacillus licheniformis having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least

90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 65, a DNase obtainable from Bacillus subtilis having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 66, a DNase obtainable from Aspergillus oryzae having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 67 or a DNase obtainable from Jrichoderma harzianum having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 68; and

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 90,

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 91 , and

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 92,

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 93, and

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 94,

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 95,

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 96,

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 97,

One preferred embodiment relates to a cleaning composition comprising;

90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 65, a DNase obtainable from Bacillus subtilis having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 66, a DNase obtainable from Aspergillus oryzae having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 67 or a DNase obtainable from Jrichoderma harzianum having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least

85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 68; and

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 98,

One preferred embodiment relates to a cleaning composition comprising;

b) at least 0.01 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 99, and

The invention further relates to cleaning compositions comprising at least one DNase, at least one hexosaminidase and at least one RNase in combination with one or more additional cleaning components. The choice of additional components is within the skill of the artisan and includes conventional ingredients, including the exemplary non-limiting components set forth below. An enzyme blend of the current invention may comprise a DNase, a hexosaminidase, preferably a b- N-acetylglucosaminidase e.g. a dispersin and an RNase. One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component.

The DNase is preferably microbial, preferably obtained from bacteria or fungi. One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, RNase and a cleaning component, wherein the DNase is microbial preferably bacteria or fungi.

In one embodiment, the DNase is obtained from bacteria. One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin, RNase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis.

The hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is preferably selected from the genus Terribacillus, preferably Terribacillus goriensis or Terribacillus saccharophilus. Alternatively, the hexosaminidase may be obtained from the genus Curtobacterium, preferably Curtobacterium oceanosedimentum, Curtobacterium flaccumfaciens, Curtobacterium luteus or Curtobacterium leaf 154. Alternatively, the hexosaminidase may be obtained from the genus Aggregatibacter, preferably Aggregatibacter actinomycetemcomitans. Alternatively, the hexosaminidase may be obtained from genus Haemophilus, preferably Haemophilus sputorum. Alternatively, the hexosaminidase may be obtained from the genus Actinobacillus, preferably Actinobacillus suis, Actinobacillus capsulatus DSM 19761, Actinobacillus equuli subsp. Equuli or Actinobacillus pleuropneumoniae. One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, glycosyl hydrolase classified as a Glyco_hydro_114 hydrolase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is obtained from Terribacillus such as Terribacillus goriensis or Terribacillus saccharophilus.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis and wherein the hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin is obtained from Curtobacterium such as Curtobacterium oceanosedimentum, Curtobacterium flaccumfaciens, Curtobacterium luteus or Curtobacterium leaf 154.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis and wherein the hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin is obtained from Aggregatibacter such as Aggregatibacter actinomycetemcomitans. One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis and wherein the hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin is obtained from Haemophilus such as Haemophilus sputorum.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis and wherein the hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin is obtained from Actinobacillus such as Actinobacillus suis, Actinobacillus capsulatus DSM 19761, Actinobacillus equuli subsp. Equuli or Actinobacillus pleuropneumoniae.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis and wherein the hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin is selected from the group consisting of;

The DNases preferably belong to the NUC1 group of DNases and comprise one or more of the motifs [T/D/S][G/N]PQL (SEQ ID NO 69), [F/L/Y/I]A[N/R]D[L/I/P/V] (SEQ ID NO: 70), or C[D/N]T[A/R] (SEQ ID NO: 71 ). The DNases even more preferably comprise a NUC1_A domain [D/Q][I/V]DH (SEQ ID NO 72), in addition to comprising any of the domain motifs [T/D/S][G/N]PQL, [F/L/Y/I]A[N/R]D[L/I/P/V] or C[D/N]T[A/R] Such DNases to be added to a composition of the invention preferably belong to the group of DNases comprised in the GYS- clade, which are group of DNases on the same branch of a phylogenetic tree having both structural and functional similarities. These NUC1 and/or NUC1_A DNases comprise the conservative motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) and share similar structural and functional properties. The DNases of the GYS-clade are preferably obtained from Bacillus genus. One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase comprises one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74). One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase comprises one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74), wherein the hexosaminidase is selected from the group consisting of;

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase comprises one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) and wherein the DNase is selected from the group consisting of:

I) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 12,

x) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 24, and y) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75% at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 25.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 13.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO: 65.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO: 66.

The DNase may also be fungal, one embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase is fungal, preferably obtained from Aspergillus and even more preferably from Aspergillus oryzae and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO: 67.

One embodiment relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase is fungal, preferably obtained from Trichoderma and even more preferably from Trichoderma harzianum and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO: 68.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least

75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 13 and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is selected from the group consisting of hexosaminidases comprising an amino acid sequence with;

xii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 93, xiii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 94,

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 65 and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is selected from the group consisting of hexosaminidases comprising an amino acid sequence with;

xvii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 98, and xviii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 99.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 66 and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is selected from the group consisting of hexosaminidases comprising an amino acid sequence with;

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 67 and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is selected from the group consisting of hexosaminidases comprising an amino acid sequence with;

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 68 and wherein the hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin is selected from the group consisting of hexosaminidases comprising an amino acid sequence with;

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the RNase is selected among polypeptides having RNase activity and comprising an amino acid sequence with: a) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 138,

b) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 139,

c) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 140,

d) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 141 ,

e) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 142,

f) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 143,

g) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 144,

h) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 145,

i) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 146,

j) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 147,

k) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 148,

L) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 149,

m) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 150,

n) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 151 ,

o) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 152,

p) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 153,

q) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 154,

r) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 155,

s) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 156.

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 13, and wherein the RNase is selected among polypeptides having RNase activity and comprising an amino acid sequence with: a) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 138,

q) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 154, r) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 155,

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 65, and wherein the RNase is selected among polypeptides having RNase activity and comprising an amino acid sequence with: a) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 138,

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 66, and wherein the RNase is selected among polypeptides having RNase activity and comprising an amino acid sequence with: a) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 138,

m) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 150, n) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 151 ,

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 67, and wherein the RNase is selected among polypeptides having RNase activity and comprising an amino acid sequence with: a) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 138,

I) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 149,

at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 155,

One embodiment of the invention relates to a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 68, and wherein the RNase is selected among polypeptides having RNase activity and comprising an amino acid sequence with: a) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 138,

i) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 146, j) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 147,

i) a NUC1 or NUC1 A DNase comprising one or more of the motifs [T/D/S][G/N]PQL (SEQ ID NO 69), [F/L/Y/I]A[N/R]D[L/I/PA/] (SEQ ID NO: 70), or C[D/N]T[A/R] (SEQ ID NO: 71 );

ii) a NUC1 or NUC1A DNase comprising the motif [D/Q][IA/]DH (SEQ ID NO 72); iii) a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74); iv) a NUC1 or NUC1A DNase comprising one or both of the motifs [V/l ] P L[S/A] N AWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76);

55, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 56, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 57, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 58, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 59, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 60, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 61 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 62, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 63, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 64, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 65, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 66, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 67, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 68;

b) at least 0.01 ppm hexosaminidase selected from the group consisting of

III. a polypeptide comprising a GH20 domain;

c) at least 0.01 ppm of an RNase having RNase activity, selected from the group of: a polypeptide having at least 80% sequence identity to SEQ ID NO: 138; a polypeptide having at least 80% sequence identity to SEQ ID NO: 139; a polypeptide having at least 80% sequence identity to SEQ ID NO: 140; a polypeptide having at least 80% sequence identity to SEQ ID NO: 141 ; a polypeptide having at least 80% sequence identity to SEQ ID NO: 142; a polypeptide having at least 80% sequence identity to SEQ ID NO: 143; a polypeptide having at least 80% sequence identity to SEQ ID NO: 144; a polypeptide having at least 80% sequence identity to SEQ ID NO: 145; a polypeptide having at least 80% sequence identity to SEQ ID NO: 146; a polypeptide having at least 80% sequence identity to SEQ ID NO: 147; a polypeptide having at least 80% sequence identity to SEQ ID NO: 148; a polypeptide having at least 80% sequence identity to SEQ ID NO: 149; a polypeptide having at least 80% sequence identity to SEQ ID NO: 150; a polypeptide having at least 80% sequence identity to SEQ ID NO: 151 ; a polypeptide having at least 80% sequence identity to SEQ ID NO: 152; a polypeptide having at least 80% sequence identity to SEQ ID NO: 153; a polypeptide having at least 80% sequence identity to SEQ ID NO: 154; a polypeptide having at least 80% sequence identity to SEQ ID NO: 155; and a polypeptide having at least 80% sequence identity to SEQ ID NO: 156, and

d) one or more cleaning components, e.g. one or more components selected from surfactants, builders, bleach components, polymers, dispersing agents and additional enzymes.

NO: 73) or ASXNRSKG (SEQ ID NO: 74), preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 82; at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; and at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 83; at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; and at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 84; at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; and at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 85; at least 10 ppm of RNase, and at least one cleaning component. One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a

NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; and at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 86; at least 10 ppm of RNase, and at least one cleaning component.

NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 87; and at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; and at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 88; at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 89; at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 90; at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 91 ; at least 10 ppm of RNase, and at least one cleaning component.

NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 92; at least 10 ppm of RNase, and at least one cleaning component.

NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 93; at least 10 ppm of RNase, and at least one cleaning component.

NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 94; at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 95; at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 96; at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 97; at least 10 ppm of RNase, and at least one cleaning component.

NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 98; at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 2, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 3, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 4, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 5, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 6, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 7, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 8, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 9, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1 1 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 12, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 13, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 14, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 15, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 16, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 17, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 18, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 19, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 20, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 21 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 22, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 23, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 99; at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a DNase sequence having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13, and at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 84 or 98, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76), preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown n SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 82, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 83, at least 10 ppm of RNase, and at least one cleaning component.

75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 84, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 85, at least 10 ppm of RNase, and at least one cleaning component.

75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 86, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 87, at least 10 ppm of RNase, and at least one cleaning component.

75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 88, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 89, at least 10 ppm of RNase, and at least one cleaning component.

75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 90, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 91 , at least 10 ppm of RNase, and at least one cleaning component.

75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 92, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 93, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 94, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 95, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 96, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 97, at least 10 ppm of RNase, and at least one cleaning component.

75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 98, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 28, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 29, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 30, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 31 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 32, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 33, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 34, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 35, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 36, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 37, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 99, at least 10 ppm of RNase, and at least one cleaning component.

[K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 82, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 83, at least 10 ppm of RNase, and at least one cleaning component.

[K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 84, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 85, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 86, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 87, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 88, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 89, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 90, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 91 , at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 92, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 93, at least 10 ppm of RNase, and at least one cleaning component.

[K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 94, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 95, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 96, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 97, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at east 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 98, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising at least 10 ppm of a NUC1 or NUC1A DNase comprising one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78) preferably the polypeptide having DNase activity is selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 39, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 40, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 43, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 44, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 45, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 46, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 47, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 48, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 49, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 50, and a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ; at least 10 ppm of hexosaminidase having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 99, at least 10 ppm of RNase, and at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

a) at least 0.01 ppm of a DNase selected from a DNase obtainable from Bacillus licheniformis having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 65, a DNase obtainable from Bacillus subtilis having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 66, a DNase obtainable from Aspergillus oryzae having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 67 or a DNase obtainable from Jrichoderma harzianum having at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide shown in SEQ ID NO: 68; and

c) at least 0.01 ppm of an RNase having at least 80% sequence identity to SEQ ID NO: 143, and d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

c) at least 0.01 ppm of an RNase having at least 80% sequence identity to SEQ ID NO: 143, and

d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

d) at least one cleaning component.

One preferred embodiment relates to a cleaning composition comprising;

d) at least one cleaning component.

Optionally the cleaning composition comprises at least 0.001 ppm of one or more protease, selected from,

i) a protease variant of a protease parent, wherein the protease variant comprises an alteration compared to a protease shown in SEQ ID NO 79 or SEQ ID NO 80 in one or more of the following positions: 3, 4, 9, 15, 24, 27, 42, 55, 59, 60, 66, 74, 85, 96, 97, 98, 99, 100, 101 , 102, 104, 1 16, 1 18, 121 , 126, 127, 128, 154, 156, 157, 158, 161 , 164, 176, 179, 182, 185, 188, 189, 193, 198, 199, 200, 203, 206, 21 1 , 212, 216, 218, 226, 229, 230, 239, 246, 255, 256, 268 and 269, wherein the positions correspond to the positions of the protease shown in SEQ ID NO 79 and wherein the protease variant has at least 80% sequence identity to SEQ ID NO 79 or SEQ ID NO 80;

ii) a protease variant of a protease parent, wherein the protease variant comprises one or more mutation selected from the group consisting of S3T, V4I, S9R, S9E, A15T, S24G, S24R, K27R, N42R, S55P, G59E, G59D, N60D, N60E, V66A, N74D, S85R, A96S, S97G, S97D, S97A, S97SD, S99E, S99D, S99G, S99M, S99N, S99R, S99H, S101A, V102I, V102Y, V102N, S104A, G1 16V, G1 16R, H1 18D, H1 18N, A120S, S126L, P127Q, S128A, S154D, A156E, G157D, G157P, S158E, Y161A, R164S, Q176E, N179E, S182E, Q185N, A188P, G189E, V193M, N198D, V199I, Y203W, S206G, L21 1 Q, L21 1 D, N212D, N212S, M216S, A226V, K229L, Q230H, Q239R, N246K, N255W, N255D, N255E, L256E, L256D T268A and R269H, wherein the positions correspond to the positions of the protease shown in SEQ ID NO 79, wherein the protease variant has at least 80% sequence identity to SEQ ID NO 79 or SEQ ID NO 80;

iii) a protease variant comprising a substitution at one or more positions corresponding to positions 171 , 173, 175, 179, or 180 of SEQ ID NO: 81 , compared to the protease shown in SEQ ID NO 81 , wherein the protease variant has a sequence identity of at least 75% but less than 100% to amino acids 1 to 31 1 of SEQ ID NO 81 ; and

iv) a protease comprising the amino acid sequence shown in SEQ ID NO 79, SEQ ID NO 80 or SEQ ID NO 81 , or a protease having at least 80% sequence identity to the polypeptide comprising amino acids 1 -269 of SEQ ID NO 79, the polypeptide comprising amino acids 1 -31 1 of SEQ ID NO 81 or the polypeptide comprising amino acids 1 -275 of SEQ ID NO 80.

Cleaning components

The choice of cleaning components may include, for textile care, the consideration of the type of textile to be cleaned, the type and/or degree of soiling, the temperature at which cleaning is to take place, and the formulation of the detergent product. Although components mentioned below are categorized by general header according to a particular functionality, this is not to be construed as a limitation, as a component may comprise additional functionalities as will be appreciated by the skilled artisan.

Surfactants

The cleaning composition may comprise one or more surfactants, which may be anionic and/or cationic and/or non-ionic and/or semi-polar and/or zwitterionic, or a mixture thereof. In a particular embodiment, the detergent composition includes a mixture of one or more nonionic surfactants and one or more anionic surfactants. The total surfactant concentration is typically from about 0.1 % to 60% by weight, such as about 1 % to about 40%, or about 3% to about 20%, or about 3% to about 10%. The choice of surfactants ) is based on the desired cleaning application, and may include any conventional surfactants known in the art.

When included therein the detergent will usually contain from about 0.1 % to about 40% by weight of an anionic surfactant, such as from about 0.25% to about 30%, including from about 0.5% to about 15%, from about 1 % to about 10%, from about 5% to about 15%, or from about 15% to about 20%, or from about 20% to about 25% of an anionic surfactant. Non-limiting examples of anionic surfactants include sulfates and sulfonates, in particular, linear alkylbenzenesulfonates (LAS), isomers of LAS, branched alkylbenzenesulfonates (BABS), phenylalkanesulfonates, alpha- olefinsulfonates (AOS), olefin sulfonates, alkene sulfonates, alkane-2, 3-diylbis(sulfates), hydroxyalkanesulfonates and disulfonates, alkyl sulfates (AS) such as sodium dodecyl sulfate (SDS), fatty alcohol sulfates (FAS), primary alcohol sulfates (PAS), alcohol ethersulfates (AES or AEOS or FES, also known as alcohol ethoxysulfates or fatty alcohol ether sulfates), secondary alkanesulfonates (SAS), paraffin sulfonates (PS), ester sulfonates, sulfonated fatty acid glycerol esters, alpha-sulfo fatty acid methyl esters (alpha-SFMe or SES) including methyl ester sulfonate (MES), alkyl- or alkenylsuccinic acid, dodecenyl/tetradecenyl succinic acid (DTSA), fatty acid derivatives of amino acids, diesters and monoesters of sulfo-succinic acid or salt of fatty acids (soap), and combinations thereof.

When included therein the detergent will usually contain from about 0.1 % to about 40% by weigh of a cationic surfactant, for example from about 0.5% to about 30%, in particular from about 1 % to about 20%, from about 3% to about 10%, such as from about 3% to about 5%, from about 8% to about 12% or from about 10% to about 12%. Non-limiting examples of cationic surfactants include alkyldimethylethanolamine quat (ADMEAQ), cetyltrimethylammonium bromide (CTAB), dimethyldistearylammonium chloride (DSDMAC), and alkylbenzyldimethylammonium, alkyl quaternary ammonium compounds, alkoxylated quaternary ammonium (AQA) compounds, ester quats, and combinations thereof.

When included therein the detergent will usually contain from about 0.2% to about 40% by weight of a nonionic surfactant, for example from about 0.5% to about 30%, in particular from about 1 % to about 20%, from about 3% to about 10%, such as from about 3% to about 5%, from about 8% to about 12%, or from about 10% to about 12%. Non-limiting examples of nonionic surfactants include alcohol ethoxylates (AE or AEO), alcohol propoxylates, propoxylated fatty alcohols (PFA), alkoxylated fatty acid alkyl esters, such as ethoxylated and/or propoxylated fatty acid alkyl esters, alkylphenol ethoxylates (APE), nonylphenol ethoxylates (NPE), alkylpolyglycosides (APG), alkoxylated amines, fatty acid monoethanolamides (FAM), fatty acid diethanolamides (FADA), ethoxylated fatty acid monoethanolamides (EFAM), propoxylated fatty acid monoethanolamides (PFAM), polyhydroxyalkyl fatty acid amides, or N-acyl N-alkyl derivatives of glucosamine (glucamides, GA, or fatty acid glucamides, FAGA), as well as products available under the trade names SPAN and TWEEN, and combinations thereof.

When included therein the detergent will usually contain from about 0.01 to about 10 % by weight of a semipolar surfactant. Non-limiting examples of semipolar surfactants include amine oxides (AO) such as alkyldimethylamineoxide, N-(coco alkyl)-N,N-dimethylamine oxide and N-(tallow- alkyl)-N,N-bis(2-hydroxyethyl)amine oxide, , and combinations thereof. When included therein the detergent will usually contain from about 0.01 % to about 10 % by weight of a zwitterionic surfactant. Non-limiting examples of zwitterionic surfactants include betaines such as alkyldimethylbetaines, sulfobetaines, and combinations thereof.

Builders and Co-Builders

The detergent composition may contain about 0-65% by weight, such as from about 0.1 % to about 65%, about 0.5% to about 60%, from about 1 % to about 60%, from about 5% to about 60%, of a detergent builder or co-builder, or a mixture thereof. In a dish wash detergent, the level of builder is typically 40-65%, particularly 50-65%. The builder and/or co-builder may particularly be a chelating agent that forms water-soluble complexes with Ca and Mg. Any builder and/or co-builder known in the art for use in cleaning detergents may be utilized. Non-limiting examples of builders include zeolites, diphosphates (pyrophosphates), triphosphates such as sodium triphosphate (STP or STPP), carbonates such as sodium carbonate, soluble silicates such as sodium metasilicate, layered silicates (e.g., SKS-6 from Hoechst), ethanolamines such as 2-aminoethan-1-ol (MEA), diethanolamine (DEA, also known as 2,2’-iminodiethan-1-ol), triethanolamine (TEA, also known as 2,2’,2”-nitrilotriethan-1 -ol), and (carboxymethyl)inulin (CMI), and combinations thereof.

The detergent composition may also contain 0-50% by weight, such as about 5% to about 30%, of a detergent co-builder. The detergent composition may include a co-builder alone, or in combination with a builder, for example a zeolite builder. Non-limiting examples of co-builders include homopolymers of polyacrylates or copolymers thereof, such as poly(acrylic acid) (PAA) or copoly(acrylic acid/maleic acid) (PAA/PMA). Further non-limiting examples include citrate, chelators such as aminocarboxylates, aminopolycarboxylates and phosphonates, and alkyl- or alkenylsuccinic acid. Additional specific examples include 2,2’,2”-nitrilotriacetic acid (NTA), ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), iminodisuccinic acid (IDS), ethylenediamine-N,N’-disuccinic acid (EDDS), methylglycinediacetic acid (MGDA), glutamic acid-N,N-diacetic acid (GLDA), 1-hydroxyethane-1 ,1 -diphosphonic acid

(HEDP), ethylenediaminetetra(methylenephosphonic acid) (EDTMPA), diethylenetriaminepentakis(methylenephosphonic acid) (DTMPA or DTPMPA), N-(2- hydroxyethyl)iminodiacetic acid (EDG), aspartic acid-N-monoacetic acid (ASMA), aspartic acid-

N,N-diacetic acid (ASDA), aspartic acid-N-monopropionic acid (ASMP), iminodisuccinic acid (IDA),

N-(2-sulfomethyl)-aspartic acid (SMAS), N-(2-sulfoethyl)-aspartic acid (SEAS), N-(2-sulfomethyl)- glutamic acid (SMGL), N-(2-sulfoethyl)-glutamic acid (SEGL), N-methyliminodiacetic acid (Ml DA), a-alanine-N,N-diacetic acid (a-ALDA), serine-N,N-diacetic acid (SEDA), isoserine-N,N-diacetic acid

(ISDA), phenylalanine-N,N-diacetic acid (PHDA), anthranilic acid-N,N-diacetic acid (ANDA), sulfanilic acid-N,N-diacetic acid (SLDA) , taurine-N,N-diacetic acid (TUDA) and sulfomethyl-N,N- diacetic acid (SMDA), N-(2-hydroxyethyl)ethylenediamine-N,N’,N”-triacetic acid (HEDTA), diethanolglycine (DEG), diethylenetriamine penta(methylenephosphonic acid) (DTPMP), aminotris(methylenephosphonic acid) (ATMP), and combinations and salts thereof. Further exemplary builders and/or co-builders are described in, e.g., WO 09/102854, US 5977053. Bleaching Systems

The cleaning composition may contain 0-30% by weight, such as from about 0.1 % to about 25%, from about 0.5% to about 25%, from about 1 % to about 20%, of a bleaching system. Any bleaching system comprising components known in the art for use in cleaning detergents may be utilized. Suitable bleaching system components include sources of hydrogen peroxide; sources of peracids; and bleach catalysts or boosters.

Sources of hydrogen peroxide:

Suitable sources of hydrogen peroxide are inorganic persalts, including alkali metal salts such as sodium percarbonate and sodium perborates (usually mono- or tetrahydrate), and hydrogen peroxide— urea (1/1 ).

Sources of peracids:

Peracids may be (a) incorporated directly as preformed peracids or (b) formed in situ in the wash liquor from hydrogen peroxide and a bleach activator (perhydrolysis) or (c) formed in situ in the wash liquor from hydrogen peroxide and a perhydrolase and a suitable substrate for the latter, e.g., an ester.

a) Suitable preformed peracids include, but are not limited to, peroxycarboxylic acids such as peroxybenzoic acid and its ring-substituted derivatives, peroxy-a-naphthoic acid, peroxyphthalic acid, peroxylauric acid, peroxystearic acid, e-phthalimidoperoxycaproic acid [phthalimidoperoxyhexanoic acid (PAP)], and o-carboxybenzamidoperoxycaproic acid; aliphatic and aromatic diperoxydicarboxylic acids such as diperoxydodecanedioic acid, diperoxyazelaic acid, diperoxysebacic acid, diperoxybrassylic acid, 2-decyldiperoxybutanedioic acid, and diperoxyphthalic, -isophthalic and -terephthalic acids; perimidic acids; peroxymonosulfuric acid; peroxydisulfuric acid; peroxyphosphoric acid; peroxysilicic acid; and mixtures of said compounds. It is understood that the peracids mentioned may in some cases be best added as suitable salts, such as alkali metal salts (e.g., Oxone®) or alkaline earth-metal salts.

b) Suitable bleach activators include those belonging to the class of esters, amides, imides, nitriles or anhydrides and, where applicable, salts thereof. Suitable examples are tetraacetylethylenediamine (TAED), sodium 4-[(3, 5, 5-trimethylhexanoyl)oxy]benzene-1 -sulfonate

(ISONOBS), sodium 4-(dodecanoyloxy)benzene-1 -sulfonate (LOBS), sodium 4-

(decanoyloxy)benzene-l -sulfonate, 4-(decanoyloxy)benzoic acid (DOBA), sodium 4-

(nonanoyloxy)benzene-l -sulfonate (NOBS), and/or those disclosed in W098/17767. A particular family of bleach activators of interest was disclosed in EP624154 and particularly preferred in that family is acetyl triethyl citrate (ATC). ATC or a short chain triglyceride like triacetin has the advantage that they are environmentally friendly. Furthermore, acetyl triethyl citrate and triacetin have good hydrolytical stability in the product upon storage and are efficient bleach activators.

Finally, ATC is multifunctional, as the citrate released in the perhydrolysis reaction may function as a builder.

Bleach catalysts and boosters

The bleaching system may also include a bleach catalyst or booster.

Some non-limiting examples of bleach catalysts that may be used in the compositions of the present invention include manganese oxalate, manganese acetate, manganese-collagen, cobalt- amine catalysts and manganese triazacyclononane (MnTACN) catalysts; particularly preferred are complexes of manganese with 1 ,4,7-trimethyl-1 ,4,7-triazacyclononane (Me3-TACN) or 1 , 2,4,7- tetramethyl-1 ,4,7-triazacyclononane (Me4-TACN), in particular Me3-TACN, such as the dinuclear manganese complex [(Me3-TACN)Mn(0)3Mn(Me3-TACN)](PF6)2, and [2,2',2"-nitrilotris(ethane- 1 ,2-diylazanylylidene-KN-methanylylidene)triphenolato-K30]manganese(lll). The bleach catalysts may also be other metal compounds; such as iron or cobalt complexes.

In some embodiments, where a source of a peracid is included, an organic bleach catalyst or bleach booster may be used having one of the following formulae:

(iii) and mixtures thereof; wherein each R1 is independently a branched alkyl group containing from 9 to 24 carbons or linear alkyl group containing from 1 1 to 24 carbons, preferably each R1 is independently a branched alkyl group containing from 9 to 18 carbons or linear alkyl group containing from 1 1 to 18 carbons, more preferably each R1 is independently selected from the group consisting of 2-propylheptyl, 2-butyloctyl, 2-pentylnonyl, 2-hexyldecyl, dodecyl, tetradecyl, hexadecyl, octadecyl, isononyl, isodecyl, isotridecyl and isopentadecyl.

Other exemplary bleaching systems are described, e.g. in W02007/087258, W02007/087244, W02007/087259, EP1867708 (Vitamin K) and W02007/087242. Suitable photobleaches may for example be sulfonated zinc or aluminium phthalocyanines.

Metal care agents

Metal care agents may prevent or reduce the tarnishing, corrosion or oxidation of metals, including aluminium, stainless steel and non-ferrous metals, such as silver and copper. Suitable examples include one or more of the following:

(a) benzatriazoles, including benzotriazole or bis-benzotriazole and substituted derivatives thereof. Benzotriazole derivatives are those compounds in which the available substitution sites on the aromatic ring are partially or completely substituted. Suitable substituents indude linear or branch-chain Ci-C20- alkyl groups (e.g., C1 -C20- alkyl groups) and hydroxyl, thio, phenyl or halogen such as fluorine, chlorine, bromine and iodine.

(b) metal salts and complexes chosen from the group consisting of zinc, manganese, titanium, zirconium, hafnium, vanadium, cobalt, gallium and cerium salts and/or complexes, the metals being in one of the oxidation states II, III, IV, V or VI. In one aspect, suitable metal salts and/or metal complexes may be chosen from the group consisting of Mn(ll) sulphate, Mn(ll) citrate, Mn(ll) stearate, Mn(ll) acetyl aceton ate, K^ATiF6 (e.g., K2TiF6), K^AZrF6 (e.g., K2ZrF6), CoS04, Co(NOs)2 and Ce(NOs)3, zinc salts, for example zinc sulphate, hydrozincite or zinc acetate.;

(c) silicates, including sodium or potassium silicate, sodium disilicate, sodium metasilicate, crystalline phyllosilicate and mixtures thereof.

Further suitable organic and inorganic redox-active substances that act as silver/copper corrosion inhibitors are disclosed in WO 94/26860 and WO 94/26859. Preferably the composition of the invention comprises from 0.1 to 5% by weight of the composition of a metal care agent, preferably the metal care agent is a zinc salt.

Hydrotropes

The cleaning composition may contain 0-10% by weight, for example 0-5% by weight, such as about 0.5 to about 5%, or about 3% to about 5%, of a hydrotrope. Any hydrotrope known in the art for use in detergents may be utilized. Non-limiting examples of hydrotropes include sodium benzenesulfonate, sodium p-toluene sulfonate (STS), sodium xylene sulfonate (SXS), sodium cumene sulfonate (SCS), sodium cymene sulfonate, amine oxides, alcohols and polyglycolethers, sodium hydroxynaphthoate, sodium hydroxynaphthalene sulfonate, sodium ethylhexyl sulfate, and combinations thereof.

Polymers

The cleaning composition may contain 0-10% by weight, such as 0.5-5%, 2-5%, 0.5-2% or 0.2-

1 % of a polymer. Any polymer known in the art for use in detergents may be utilized. The polymer may function as a co-builder as mentioned above, or may provide antiredeposition, fiber protection, soil release, dye transfer inhibition, grease cleaning and/or anti-foaming properties. Some polymers may have more than one of the above-mentioned properties and/or more than one of the below- mentioned motifs. Exemplary polymers include (carboxymethyl)cellulose (CMC), poly(vinyl alcohol)

(PVA), poly(vinylpyrrolidone) (PVP), poly(ethyleneglycol) or polyethylene oxide) (PEG), ethoxylated poly(ethyleneimine), carboxymethyl inulin (CMI), and polycarboxylates such as PAA,

PAA/PMA, poly-aspartic acid, and lauryl methacrylate/acrylic acid copolymers , hydrophobically modified CMC (HM-CMC) and silicones, copolymers of terephthalic acid and oligomeric glycols, copolymers of poly(ethylene terephthalate) and poly(oxyethene terephthalate) (PET-POET), PVP, poly(vinylimidazole) (PVI), poly(vinylpyridine-N-oxide) (PVPO or PVPNO) and polyvinylpyrrolidone- vinylimidazole (PVPVI). Suitable examples include PVP-K15, PVP-K30, ChromaBond S-400, ChromaBond S- 403E and Chromabond S-100 from Ashland Aqualon, and Sokalan® HP 165, Sokalan® HP 50 (Dispersing agent), Sokalan® HP 53 (Dispersing agent), Sokalan® HP 59 (Dispersing agent), Sokalan® HP 56 (dye transfer inhibitor), Sokalan® HP 66 K (dye transfer inhibitor) from BASF. Further exemplary polymers include sulfonated polycarboxylates, polyethylene oxide and polypropylene oxide (PEO-PPO) and diquaternium ethoxy sulfate. Other exemplary polymers are disclosed in, e.g., WO 2006/130575. Salts of the above-mentioned polymers are also contemplated. Particularly preferred polymer is ethoxylated homopolymer Sokalan® HP 20 from BASF, which helps to prevent redeposition of soil in the wash liquor.

Fabric hueinq agents

The cleaning composition of the present invention may also include fabric hueing agents such as dyes or pigments, which when formulated in detergent compositions can deposit onto a fabric when said fabric is contacted with a wash liquor comprising said detergent compositions and thus altering the tint of said fabric through absorption/reflection of visible light. Fluorescent whitening agents emit at least some visible light. In contrast, fabric hueing agents alter the tint of a surface as they absorb at least a portion of the visible light spectrum. Suitable fabric hueing agents include dyes and dye-clay conjugates, and may also include pigments. Suitable dyes include small molecule dyes and polymeric dyes. Suitable small molecule dyes include small molecule dyes selected from the group consisting of dyes falling into the Colour Index (C.l.) classifications of Direct Blue, Direct Red, Direct Violet, Acid Blue, Acid Red, Acid Violet, Basic Blue, Basic Violet and Basic Red, or mixtures thereof, for example as described in W02005/03274, W02005/03275, W02005/03276 and EP1876226 (hereby incorporated by reference). The detergent composition preferably comprises from about 0.00003 wt% to about 0.2 wt%, from about 0.00008 wt% to about 0.05 wt%, or even from about 0.0001 wt% to about 0.04 wt% fabric hueing agent. The composition may comprise from 0.0001 wt% to 0.2 wt% fabric hueing agent, this may be especially preferred when the composition is in the form of a unit dose pouch. Suitable hueing agents are also disclosed in, e.g. WO 2007/087257 and W02007/087243.

Enzymes

The cleaning composition may comprise one or more additional enzymes such as one or more protease, lipase, cutinase, an amylase, carbohydrase, cellulase, pectinase, mannanase, arabinase, galactanase, xylanase, oxidase, e.g., a laccase, and/or peroxidase.

In general, the properties of the selected enzyme(s) should be compatible with the selected detergent, (i.e., pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts.

Proteases

Suitable proteases for the compositions of the invention include those of bacterial, fungal, plant, viral or animal origin e.g. vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included. It may be an alkaline protease, such as a serine protease or a metalloprotease. A serine protease may for example be of the S1 family, such as trypsin, or the S8 family such as subtilisin. A metalloproteases protease may for example be a thermolysin from e.g. family M4 or other metalloprotease such as those from M5, M7 or M8 families.

Examples of subtilases are those derived from Bacillus such as Bacillus lentus, Bacillus alkalophilus, Bacillus subtilis, Bacillus amyloliquefaciens, Bacillus pumilus and Bacillus gibsonii described in; US7262042 and W009/021867. Subtilisin lentus, Subtilisin Novo, subtilisin Carlsberg, Bacillus licheniformis, subtilisin BPN’, subtilisin 309, subtilisin 147 and subtilisin 168 and e.g. protease PD138 described in (WO93/18140). Other useful proteases may be those described in W001/016285 and W002/016547. Examples of trypsin-like proteases are trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in W094/25583 and W005/040372, and the chymotrypsin proteases derived from Cellumonas described in W005/052161 and W005/052146.

A further preferred protease is the alkaline protease from Bacillus lentus DSM 5483, as described for example in W095/23221 , and variants thereof which are described in WO92/21760, W095/23221 , EP1921 147 and EP1921 148.

Examples of metalloproteases are the neutral metalloprotease as described in WO07/044993 (Procter & Gamble/Genencor Int.) such as those derived from Bacillus amyloliquefaciens.

Examples of useful proteases are the variants described in: WO89/06279, W092/19729,

WO96/034946, WO98/201 15, WO98/201 16, WO99/01 1768, WO01/44452, W003/006602,

W004/03186, W004/041979, W007/006305, W01 1/036263, W01 1/036264, especially the variants with substitutions in one or more of the following positions: 3, 4, 9, 15, 24, 27, 42, 55,

59, 60, 66, 74, 85, 96, 97, 98, 99, 100, 101 , 102, 104, 1 16, 1 18, 121 , 126, 127, 128, 154, 156,

157, 158, 161 , 164, 176, 179, 182, 185, 188, 189, 193, 198, 199, 200, 203, 206, 21 1 , 212, 216,

218, 226, 229, 230, 239, 246, 255, 256, 268 and 269 wherein the positions correspond to the positions of the Bacillus lentus protease shown in SEQ ID NO 79. More preferred the protease variants may comprise one or more of the mutations selected from the group consisting of: S3T,

V4I, S9R, S9E, A15T, S24G, S24R, K27R, N42R, S55P, G59E, G59D, N60D, N60E, V66A,

N74D, S85R, A96S, S97G, S97D, S97A, S97SD, S99E, S99D, S99G, S99M, S99N, S99R,

S99H, S101A, V102I, V102Y, V102N, S104A, G1 16V, G1 16R, H1 18D, H1 18N, A120S, S126L,

P127Q, S128A, S154D, A156E, G157D, G157P, S158E, Y161A, R164S, Q176E, N179E,

S182E, Q185N, A188P, G189E, V193M, N198D, V199I, Y203W, S206G, L21 1 Q, L21 1 D,

N212D, N212S, M216S, A226V, K229L, Q230H, Q239R, N246K, N255W, N255D, N255E,

L256E, L256D T268A and R269H. The protease variants are preferably variants of the Bacillus lentus protease (Savinase®) shown in SEQ ID NO 79, the Bacillus amylolichenifaciens protease (BPN’) shown in SEQ ID NO 80. The protease variants preferably have at least 80 % sequence identity to SEQ ID NO 79 or SEQ ID NO 80 of WO 2016/001449.

A protease variant comprising a substitution at one or more positions corresponding to positions 171 , 173, 175, 179, or 180 of SEQ ID NO: 81 , wherein said protease variant has a sequence identity of at least 75% but less than 100% to SEQ ID NO: 81 .

Suitable commercially available protease enzymes include those sold under the trade names Alcalase®, Duralase^Tm, Durazyrn^Tm, Relase®, Relase® Ultra, Savinase®, Savinase® Ultra, Primase®, Polarzyme®, Kannase®, Liquanase®, Liquanase® Ultra, Ovozyme®, Coronase®, Coronase® Ultra, Blaze®, Blaze Evity® 100T, Blaze Evity® 125T, Blaze Evity® 150T, Neutrase®, Everlase®, Esperase®, Progress® Uno, Progress® Excel and Progress® In (Novozymes A/S), those sold under the tradename Maxatase®, Maxacal®, Maxapem®, Purafect Ox®, Purafect OxP®, Puramax®, FN2®, FN3®, FN4®, Excellase®, Excellenz P1000™, Excellenz P1250™, Eraser®, Preferenz P100™, Purafect Prime®, Preferenz P1 10™, Effectenz P1000™, Purafect®™, Effectenz P1050™, Purafect Ox®™, Effectenz P2000™, Purafast®, Properase®, Opticlean®, Optimase®, and Preferenz™ P300 (Danisco/DuPont), Axapem™ (Gist-Brocases N.V.), BLAP (sequence shown in Figure 29 of US5352604) and variants hereof (Henkel AG) and KAP ( Bacillus alkalophilus subtilisin) from Kao.

Cellulases

Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g., the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in US 4,435,307, US 5,648,263, US 5,691 ,178, US 5,776,757 and WO 89/09259.

Especially suitable cellulases are the alkaline or neutral cellulases having colour care benefits. Examples of such cellulases are cellulases described in EP 0 495 257, EP 0 531 372, WO 96/1 1262, WO 96/29397, WO 98/08940. Other examples are cellulase variants such as those described in WO 94/07998, EP 0 531 315, US 5,457,046, US 5,686,593, US 5,763,254, WO 95/24471 , WO 98/12307 and W099/001544.

Other cellulases are endo-beta-1 ,4-glucanase enzyme having a sequence of at least 97% identity to the amino acid sequence of position 1 to position 773 of SEQ ID NO:2 of WO 2002/099091 or a family 44 xyloglucanase, which a xyloglucanase enzyme having a sequence of at least 60% identity to positions 40-559 of SEQ ID NO: 2 of WO 2001/062903.

Commercially available cellulases include Celluzyme™, and Carezyme™ (Novozymes A/S) Carezyme Premium™ (Novozymes A/S), Celluclean™ (Novozymes A/S), Celluclean Classic™ (Novozymes A/S), Cellusoft™ (Novozymes A/S), Whitezyme™ (Novozymes A/S), Clazinase™, and Puradax HA™ (Genencor International Inc.), and KAC-500(B)™ (Kao Corporation).

Mannanases Suitable mannanases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included. The mannanase may be an alkaline mannanase of Family 5 or 26. It may be a wild-type from Bacillus or Humicola, particularly B. agaradhaerens, B. licheniformis, B. halodurans, B. clausii, or H. insolens. Suitable mannanases are described in WO 1999/064619. A commercially available mannanase is Mannaway (Novozymes A/S).

Peroxidases/Oxidases

Suitable peroxidases/oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g., from C. cinereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257. Commercially available peroxidases include Guardzyme™ (Novozymes A/S).

Lipases and Cutinases:

Suitable lipases and cutinases include those of bacterial or fungal origin. Chemically modified or protein engineered mutant enzymes are included. Examples include lipase from Thermomyces, e.g. from T. lanuginosus (previously named Humicola lanuginosa) as described in EP258068 and EP305216, cutinase from Humicola, e.g. H. insolens (WO96/13580), lipase from strains of Pseudomonas (some of these now renamed to Burkholderia), e.g. P. alcaligenes or P. pseudoalcaligenes (EP218272), P. cepacia (EP331376), P. sp. strain SD705 (W095/06720 & W096/27002), P. wisconsinensis (WO96/12012), GDSL-type Streptomyces lipases (W010/065455), cutinase from Magnaporthe grisea (W010/107560), cutinase from Pseudomonas mendocina (US5,389,536), lipase from Thermobifida fusca (W01 1/084412), Geobacillus stearothermophilus lipase (W01 1/084417), lipase from Bacillus subtilis (W01 1/084599), and lipase from Streptomyces griseus (W01 1/150157) and S. pristinaespiralis (W012/137147).

Other examples are lipase variants such as those described in EP407225, WO92/05249, WO94/01541 , W094/25578, W095/14783, WO95/30744, W095/35381 , W095/22615,

W096/00292, W097/04079, W097/07202, WO00/34450, WO00/60063, W001/92502,

W007/87508 and WO09/109500.

Preferred commercial lipase products include LipolaseTM, Lipex™; LipolexTM and LipocleanTM (Novozymes A/S), Lumafast (originally from Genencor) and Lipomax (originally from Gist- Brocades).

Still other examples are lipases sometimes referred to as acyltransferases or perhydrolases, e.g. acyltransferases with homology to Candida antarctica lipase A (WO10/11 1 143), acyltransferase from Mycobacterium smegmatis (WO05/56782), perhydrolases from the CE 7 family (WO09/67279), and variants of the M. smegmatis perhydrolase in particular the S54V variant used in the commercial product Gentle Power Bleach from Huntsman Textile Effects Pte Ltd (W010/100028).

Amylases: Suitable amylases include alpha-amylases and/or a glucoamylases and may be of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, alpha-amylases obtained from Bacillus, e.g., a special strain of Bacillus licheniformis, described in more detail in GB 1 ,296,839.

Suitable amylases include amylases having SEQ ID NO: 2 in WO 95/10603 or variants having 90% sequence identity to SEQ ID NO: 3 thereof. Preferred variants are described in WO 94/02597, WO 94/18314, WO 97/43424 and SEQ ID NO: 4 of WO 99/019467, such as variants with substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 178, 179, 181 , 188, 190, 197, 201 , 202, 207, 208, 209, 211 , 243, 264, 304, 305, 391 , 408, and 444.

Different suitable amylases include amylases having SEQ ID NO: 6 in WO 02/010355 or variants thereof having 90% sequence identity to SEQ ID NO: 6. Preferred variants of SEQ ID NO: 6 are those having a deletion in positions 181 and 182 and a substitution in position 193.

Other amylases which are suitable are hybrid alpha-amylase comprising residues 1 -33 of the alpha-amylase derived from B. amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006/066594 and residues 36-483 of the B. licheniformis alpha-amylase shown in SEQ ID NO: 4 of WO 2006/066594 or variants having 90% sequence identity thereof. Preferred variants of this hybrid alpha-amylase are those having a substitution, a deletion or an insertion in one of more of the following positions: G48, T49, G107, H156, A181 , N190, M197, 1201 , A209 and Q264. Most preferred variants of the hybrid alpha-amylase comprising residues 1-33 of the alpha-amylase derived from B. amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006/066594 and residues 36-483 of SEQ ID NO: 4 are those having the substitutions:

M197T;

H156Y+A181T+N190F+A209V+Q264S; or

G48A+T49I+G107A+H156Y+A181T+N190F+I201 F+A209V+Q264S.

Further amylases which are suitable are amylases having SEQ ID NO: 6 in WO 99/019467 or variants thereof having 90% sequence identity to SEQ ID NO: 6. Preferred variants of SEQ ID NO: 6 are those having a substitution, a deletion or an insertion in one or more of the following positions: R181 , G182, H183, G184, N195, 1206, E212, E216 and K269. Particularly preferred amylases are those having deletion in positions R181 and G182, or positions H183 and G184.

Additional amylases which can be used are those having SEQ ID NO: 1 , SEQ ID NO: 3, SEQ

ID NO: 2 or SEQ ID NO: 7 of WO 96/023873 or variants thereof having 90% sequence identity to

SEQ ID NO: 1 , SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 7. Preferred variants of SEQ ID NO:

1 , SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 7 are those having a substitution, a deletion or an insertion in one or more of the following positions: 140, 181 , 182, 183, 184, 195, 206, 212, 243,

260, 269, 304 and 476, using SEQ ID 2 of WO 96/023873 for numbering. More preferred variants are those having a deletion in two positions selected from 181 , 182, 183 and 184, such as 181 and

182, 182 and 183, or positions 183 and 184. Most preferred amylase variants of SEQ ID NO: 1 ,

SEQ ID NO: 2 or SEQ ID NO: 7 are those having a deletion in positions 183 and 184 and a substitution in one or more of positions 140, 195, 206, 243, 260, 304 and 476.

Other amylases which can be used are amylases having SEQ ID NO: 2 of WO 08/153815, SEQ ID NO: 10 in WO 01/66712 or variants thereof having 90% sequence identity to SEQ ID NO: 2 of WO 08/153815 or 90% sequence identity to SEQ ID NO: 10 in WO 01/66712. Preferred variants of SEQ ID NO: 10 in WO 01/66712 are those having a substitution, a deletion or an insertion in one of more of the following positions: 176, 177, 178, 179, 190, 201 , 207, 21 1 and 264.

Further suitable amylases are amylases having SEQ ID NO: 2 of WO 09/061380 or variants having 90% sequence identity to SEQ ID NO: 2 thereof. Preferred variants of SEQ ID NO: 2 are those having a truncation of the C-terminus and/or a substitution, a deletion or an insertion in one of more of the following positions: Q87, Q98, S125, N128, T131 , T165, K178, R180, S181 , T182, G183, M201 , F202, N225, S243, N272, N282, Y305, R309, D319, Q320, Q359, K444 and G475. More preferred variants of SEQ ID NO: 2 are those having the substitution in one of more of the following positions: Q87E,R, Q98R, S125A, N128C, T131 I, T165I, K178L, T182G, M201 L, F202Y, N225E,R, N272E,R, S243Q,A,E,D, Y305R, R309A, Q320R, Q359E, K444E and G475K and/or deletion in position R180 and/or S181 or of T182 and/or G183. Most preferred amylase variants of SEQ ID NO: 2 are those having the substitutions:

N128C+K178L+T182G+Y305R+G475K;

N 128C+K178L+T182G+F202Y+Y305R+D319T+G475K;

S125A+N128C+K178L+T182G+Y305R+G475K; or

S125A+N 128C+T1311+T165I+K178L+T182G+Y305R+G475K wherein the variants are C- terminally truncated and optionally further comprises a substitution at position 243 and/or a deletion at position 180 and/or position 181.

Further suitable amylases are amylases having SEQ ID NO: 1 of W013184577 or variants having 90% sequence identity to SEQ ID NO: 1 thereof. Preferred variants of SEQ ID NO: 1 are those having a substitution, a deletion or an insertion in one of more of the following positions: K176, R178, G179, T180, G181 , E187, N192, M199, I203, S241 , R458, T459, D460, G476 and G477. More preferred variants of SEQ ID NO: 1 are those having the substitution in one of more of the following positions: K176L, E187P, N192FYH, M199L, I203YF, S241 QADN, R458N, T459S, D460T, G476K and G477K and/or deletion in position R178 and/or S179 or of T180 and/or G181. Most preferred amylase variants of SEQ ID NO: 1 are those having the substitutions:

E187P+I203Y+G476K

E187P+I203Y+R458N+T459S+D460T+G476K

wherein the variants optionally further comprise a substitution at position 241 and/or a deletion at position 178 and/or position 179.

Further suitable amylases are amylases having SEQ ID NO: 1 of W010104675 or variants having 90% sequence identity to SEQ ID NO: 1 thereof. Preferred variants of SEQ ID NO: 1 are those having a substitution, a deletion or an insertion in one of more of the following positions: N21 ,

D97, V128 K177, R179, S180, 1181 , G182, M200, L204, E242, G477 and G478. More preferred variants of SEQ ID NO: 1 are those having the substitution in one of more of the following positions: N21 D, D97N, V128I K177L, M200L, L204YF, E242QA, G477K and G478K and/or deletion in position R179 and/or S180 or of 1181 and/or G182. Most preferred amylase variants of SEQ ID NO: 1 are those having the substitutions:

N21 D+D97N+V128I

wherein the variants optionally further comprise a substitution at position 200 and/or a deletion at position 180 and/or position 181.

Other suitable amylases are the alpha-amylase having SEQ ID NO: 12 in WO01/66712 or a variant having at least 90% sequence identity to SEQ ID NO: 12. Preferred amylase variants are those having a substitution, a deletion or an insertion in one of more of the following positions of SEQ ID NO: 12 in WO01/66712: R28, R118, N174; R181 , G182, D183, G184, G186, W189, N195, M202, Y298, N299, K302, S303, N306, R310, N314; R320, H324, E345, Y396, R400, W439, R444, N445, K446, Q449, R458, N471 , N484. Particular preferred amylases include variants having a deletion of D183 and G184 and having the substitutions R118K, N195F, R320K and R458K, and a variant additionally having substitutions in one or more position selected from the group: M9, G149, G182, G186, M202, T257, Y295, N299, M323, E345 and A339, most preferred a variant that additionally has substitutions in all these positions.

Other examples are amylase variants such as those described in WO2011/098531 , WO2013/001078 and WO2013/001087.

Commercially available amylases are DuramylTM, TermamylTM, FungamylTM, Stainzyme TM, Stainzyme PlusTM, NatalaseTM, Liquozyme X and BANTM (from Novozymes A/S), and RapidaseTM, PurastarTM/EffectenzTM, Powerase, Preferenz S1000, Preferenz S100 and Preferenz S1 10 (from Genencor International Inc./DuPont).

Peroxidases/Oxidases

A peroxidase according to the invention is a peroxidase enzyme comprised by the enzyme classification EC 1.1 1.1.7, as set out by the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (IUBMB), or any fragment derived therefrom, exhibiting peroxidase activity.

Suitable peroxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinopsis, e.g., from C. cinerea (EP 179,486), and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257.

A suitable peroxidase includes a haloperoxidase enzyme, such as chloroperoxidase, bromoperoxidase and compounds exhibiting chloroperoxidase or bromoperoxidase activity.

Haloperoxidases are classified according to their specificity for halide ions. Chloroperoxidases (E.C.

1.1 1.1.10) catalyze formation of hypochlorite from chloride ions. Preferably, the haloperoxidase is a vanadium haloperoxidase, i.e., a vanadate-containing haloperoxidase. Haloperoxidases have been isolated from many different fungi, in particular from the fungus group dematiaceous hyphomycetes, such as Caldariomyces, e.g., C. fumago, Alternaria, Curvularia, e.g., C. verruculosa and C. inaequalis, Drechslera, Ulocladium and Botrytis.

Haloperoxidases have also been isolated from bacteria such as Pseudomonas, e.g., P. pyrrocinia and Streptomyces, e.g., S. aureofaciens.

A suitable oxidase includes in particular, any laccase enzyme comprised by the enzyme classification EC 1.10.3.2, or any fragment derived therefrom exhibiting laccase activity, or a compound exhibiting a similar activity, such as a catechol oxidase (EC 1.10.3.1 ), an o-aminophenol oxidase (EC 1.10.3.4), or a bilirubin oxidase (EC 1.3.3.5). Preferred laccase enzymes are enzymes of microbial origin. The enzymes may be derived from plants, bacteria or fungi (including filamentous fungi and yeasts). Suitable examples from fungi include a laccase derivable from a strain of Aspergillus, Neurospora, e.g., N. crassa, Podospora, Botrytis, Collybia, Fomes, Lentinus, Pleurotus, Trametes, e.g., T. villosa and T. versicolor, Rhizoctonia, e.g., R. solani, Coprinopsis, e.g., C. cinerea, C. comatus, C. friesii, and C. plicatilis, Psathyrella, e.g., P. condelleana, Panaeolus, e.g., P. papilionaceus, Myceliophthora, e.g., M. thermophila, Schytalidium, e.g., S. thermophilum, Polyporus, e.g., P. pinsitus, Phlebia, e.g., P. radiata (WO 92/01046), or Coriolus, e.g., C. hirsutus (JP 2238885). Suitable examples from bacteria include a laccase derivable from a strain of Bacillus. A laccase derived from Coprinopsis or Myceliophthora is preferred; in particular, a laccase derived from Coprinopsis cinerea, as disclosed in WO 97/08325; or from Myceliophthora thermophila, as disclosed in WO 95/33836.

Dispersants

The cleaning composition of the present invention can also contain dispersants. In particular, powdered detergents may comprise dispersants. Suitable water-soluble organic materials include the homo- or co-polymeric acids or their salts, in which the polycarboxylic acid comprises at least two carboxyl radicals separated from each other by not more than two carbon atoms. Suitable dispersants are for example described in Powdered Detergents, Surfactant science series volume 71 , Marcel Dekker, Inc.

Dye Transfer Inhibiting Agents

The cleaning composition of the present invention may also include one or more dye transfer inhibiting agents. Suitable polymeric dye transfer inhibiting agents include, but are not limited to, polyvinylpyrrolidone polymers, polyamine N-oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof. When present in a subject composition, the dye transfer inhibiting agents may be present at levels from about 0.0001 % to about 10%, from about 0.01 % to about 5% or even from about 0.1 % to about 3% by weight of the composition. Fluorescent whitening agent

The cleaning composition of the present invention will preferably also contain additional components that may tint articles being cleaned, such as fluorescent whitening agent or optical brighteners. Where present the brightener is preferably at a level of about 0.01 % to about 0.5%. Any fluorescent whitening agent suitable for use in a laundry detergent composition may be used in the composition of the present invention. The most commonly used fluorescent whitening agents are those belonging to the classes of diaminostilbene-sulfonic acid derivatives, diarylpyrazoline derivatives and bisphenyl-distyryl derivatives. Examples of the diaminostilbene-sulfonic acid derivative type of fluorescent whitening agents include the sodium salts of: 4,4'-bis-(2- diethanolamino-4-anilino-s-triazin-6-ylamino) stilbene-2,2'-disulfonate, 4,4'-bis-(2,4-dianilino-s- triazin-6-ylamino) stilbene-2.2'-disulfonate, 4,4'-bis-(2-anilino-4-(N-methyl-N-2-hydroxy- ethylamino)-s-triazin-6-ylamino) stilbene-2,2'-disulfonate, 4,4'-bis-(4-phenyl-1 ,2,3-triazol-2- yl)stilbene-2,2'-disulfonate and sodium 5-(2H-naphtho[1 ,2-d][1 ,2,3]triazol-2-yl)-2-[(E)-2- phenylvinyl]benzenesulfonate. Preferred fluorescent whitening agents are Tinopal DMS and Tinopal CBS available from Ciba-Geigy AG, Basel, Switzerland. Tinopal DMS is the disodium salt of 4,4'-bis-(2-morpholino-4-anilino-s-triazin-6-ylamino) stilbene-2,2'-disulfonate. Tinopal CBS is the disodium salt of 2,2'-bis-(phenyl-styryl)-disulfonate. Also preferred are fluorescent whitening agents is the commercially available Parawhite KX, supplied by Paramount Minerals and Chemicals, Mumbai, India. Other fluorescers suitable for use in the invention include the 1-3-diaryl pyrazolines and the 7-alkylaminocoumarins. Suitable fluorescent brightener levels include lower levels of from about 0.01 , from 0.05, from about 0.1 or even from about 0.2 wt % to upper levels of 0.5 or even 0.75 wt%.

Soil release polymers

The cleaning composition of the present invention may also include one or more soil release polymers which aid the removal of soils from fabrics such as cotton and polyester based fabrics, in particular the removal of hydrophobic soils from polyester based fabrics. The soil release polymers may for example be nonionic or anionic terephthalte based polymers, polyvinyl caprolactam and related copolymers, vinyl graft copolymers, polyester polyamides see for example Chapter 7 in

Powdered Detergents, Surfactant science series volume 71 , Marcel Dekker, Inc. Another type of soil release polymers is amphiphilic alkoxylated grease cleaning polymers comprising a core structure and a plurality of alkoxylate groups attached to that core structure. The core structure may comprise a polyalkylenimine structure or a polyalkanolamine structure as described in detail in WO

2009/087523 (hereby incorporated by reference). Furthermore, random graft co-polymers are suitable soil release polymers. Suitable graft co-polymers are described in more detail in WO

2007/138054, WO 2006/108856 and WO 2006/1 13314 (hereby incorporated by reference).

Suitable polyethylene glycol polymers include random graft co-polymers comprising: (i) hydrophilic backbone comprising polyethylene glycol; and (ii) side chain(s) selected from the group consisting of: C4-C25 alkyl group, polypropylene, polybutylene, vinyl ester of a saturated C1-C6 mono- carboxylic acid, Cl-C 6 alkyl ester of acrylic or methacrylic acid, and mixtures thereof. Suitable polyethylene glycol polymers have a polyethylene glycol backbone with random grafted polyvinyl acetate side chains. The average molecular weight of the polyethylene glycol backbone can be in the range of from 2,000 Da to 20,000 Da, or from 4,000 Da to 8,000 Da. The molecular weight ratio of the polyethylene glycol backbone to the polyvinyl acetate side chains can be in the range of from 1 : 1 to 1 :5, or from 1 : 1.2 to 1 :2. The average number of graft sites per ethylene oxide units can be less than 1 , or less than 0.8, the average number of graft sites per ethylene oxide units can be in the range of from 0.5 to 0.9, or the average number of graft sites per ethylene oxide units can be in the range of from 0.1 to 0.5, or from 0.2 to 0.4. A suitable polyethylene glycol polymer is Sokalan HP22. Other soil release polymers are substituted polysaccharide structures especially substituted cellulosic structures such as modified cellulose deriviatives such as those described in EP 1867808 or WO 2003/040279 (both are hereby incorporated by reference). Suitable cellulosic polymers include cellulose, cellulose ethers, cellulose esters, cellulose amides and mixtures thereof. Suitable cellulosic polymers include anionically modified cellulose, nonionically modified cellulose, cationically modified cellulose, zwitterionically modified cellulose, and mixtures thereof. Suitable cellulosic polymers include methyl cellulose, carboxy methyl cellulose, ethyl cellulose, hydroxyl ethyl cellulose, hydroxyl propyl methyl cellulose, ester carboxy methyl cellulose, and mixtures thereof.

Anti-redeposition agents

The cleaning composition of the present invention may also include one or more anti- redeposition agents such as carboxymethylcellulose (CMC), polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), polyoxyethylene and/or polyethyleneglycol (PEG), homopolymers of acrylic acid, copolymers of acrylic acid and maleic acid, and ethoxylated polyethyleneimines. The cellulose based polymers described under soil release polymers above may also function as anti- redeposition agents.

Rheology Modifiers

The cleaning composition of the present invention may also include one or more rheology modifiers, structurants or thickeners, as distinct from viscosity reducing agents. The rheology modifiers are selected from the group consisting of non-polymeric crystalline, hydroxy-functional materials, polymeric rheology modifiers which impart shear thinning characteristics to the aqueous liquid matrix of a liquid detergent composition. The rheology and viscosity of the detergent can be modified and adjusted by methods known in the art, for example as shown in EP 2169040.

Other suitable cleaning composition components include, but are not limited to, anti-shrink agents, anti-wrinkling agents, bactericides, binders, carriers, dyes, enzyme stabilizers, fabric softeners, fillers, foam regulators, hydrotropes, perfumes, pigments, sod suppressors, solvents, and structurants for liquid detergents and/or structure elasticizing agents.

Formulation of cleaning compositions

The cleaning composition of the invention may be in any convenient form, e.g., a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular, compact or concentrated liquid.

Pouches can be configured as single or multicompartments. It can be of any form, shape and material which is suitable for hold the composition, e.g. without allowing the release of the composition to release of the composition from the pouch prior to water contact. The pouch is made from water soluble film which encloses an inner volume. Said inner volume can be divided into compartments of the pouch. Preferred films are polymeric materials preferably polymers which are formed into a film or sheet. Preferred polymers, copolymers or derivates thereof are selected polyacrylates, and water soluble acrylate copolymers, methyl cellulose, carboxy methyl cellulose, sodium dextrin, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, malto dextrin, poly methacrylates, most preferably polyvinyl alcohol copolymers and, hydroxypropyl methyl cellulose (HPMC). Preferably the level of polymer in the film for example PVA is at least about 60%. Preferred average molecular weight will typically be about 20,000 to about 150,000. Films can also be of blended compositions comprising hydrolytically degradable and water soluble polymer blends such as polylactide and polyvinyl alcohol (known under the Trade reference M8630 as sold by MonoSol LLC, Indiana, USA) plus plasticisers like glycerol, ethylene glycerol, propylene glycol, sorbitol and mixtures thereof. The pouches can comprise a solid laundry cleaning composition or part components and/or a liquid cleaning composition or part components separated by the water-soluble film. The compartment for liquid components can be different in composition than compartments containing solids: US2009/0011970 A1.

Detergent ingredients can be separated physically from each other by compartments in water dissolvable pouches or in different layers of tablets. Thereby negative storage interaction between components can be avoided. Different dissolution profiles of each of the compartments can also give rise to delayed dissolution of selected components in the wash solution.

A liquid or gel detergent, which is not unit dosed, may be aqueous, typically containing at least 20% by weight and up to 95% water, such as up to about 70% water, up to about 65% water, up to about 55% water, up to about 45% water, up to about 35% water. Other types of liquids, including without limitation, alkanols, amines, diols, ethers and polyols may be included in an aqueous liquid or gel. An aqueous liquid or gel detergent may contain from 0-30% organic solvent. A liquid or gel detergent may be non-aqueous.

Granular detergent formulations

The composition(s) of the invention may be formulated as a granule for example as a co-granule that combines one or more enzymes. Each enzyme will then be present in more granules securing a more uniform distribution of enzymes in the detergent. This also reduces the physical segregation of different enzymes due to different particle sizes. Methods for producing multi-enzyme co- granulates for the detergent industry are disclosed in the IP.com disclosure IPCOM000200739D.

Another example of formulation of enzymes by the use of co-granulates are disclosed in WO 2013/188331 , which relates to a detergent composition comprising (a) a multi-enzyme co- granule; (b) less than 10 wt zeolite (anhydrous basis); and (c) less than 10 wt phosphate salt (anhydrous basis), and the composition additionally comprises from 20 to 80 wt% detergent moisture sink component. The multi-enzyme co-granule may comprise an enzyme blend i.e. at least one DNase, at least one hexosaminidase, at least one Glyco_hydro_1 14 hydrolase and/or RNase and one or more enzymes selected from the group consisting of proteases, lipases, cellulases, xyloglucanases, perhydrolases, peroxidases, lipoxygenases, laccases, hemicellulases, cellulases, cellobiose dehydrogenases, xylanases, phospho lipases, esterases, cutinases, pectinases, mannanases, pectate lyases, keratinases, reductases, oxidases, phenoloxidases, ligninases, pullulanases, tannases, pentosanases, lichenases glucanases, arabinosidases, hyaluronidase, chondroitinase, amylases, and mixtures thereof.

WO 2013/188331 also relates to a method of treating and/or cleaning a surface, preferably a fabric surface comprising the steps of (i) contacting said surface with the detergent composition as claimed and described herein in aqueous wash liquor, (ii) rinsing and/or drying the surface.

An embodiment of the invention relates to an enzyme granule/particle comprising the DNase, hexosaminidase and/or Glyco_hydro_1 14 hydrolase and/or RNase. The granule is composed of a core, and optionally one or more coatings (outer layers) surrounding the core.

Typically, the granule/particle size, measured as equivalent spherical diameter (volume based average particle size), of the granule is 20-2000 pm, particularly 50-1500 pm, 100-1500 pm or 250-1200 pm. The core may include additional materials such as fillers, fibre materials (cellulose or synthetic fibres), stabilizing agents, solubilising agents, suspension agents, viscosity regulating agents, light spheres, plasticizers, salts, lubricants and fragrances. The core may include binders, such as synthetic polymer, wax, fat, or carbohydrate. The core may comprise a salt of a multivalent cation, a reducing agent, an antioxidant, a peroxide decomposing catalyst and/or an acidic buffer component, typically as a homogenous blend. The core may consist of an inert particle with the enzyme absorbed into it, or applied onto the surface, e.g., by fluid bed coating. The core may have a diameter of 20-2000 pm, particularly 50-1500 pm, 100-1500 pm or 250-1200 pm. The core can be prepared by granulating a blend of the ingredients, e.g., by a method comprising granulation techniques such as crystallization, precipitation, pan-coating, fluid bed coating, fluid bed agglomeration, rotary atomization, extrusion, prilling, spheronization, size reduction methods, drum granulation, and/or high shear granulation.

Methods for preparing the core can be found in Handbook of Powder Technology; Particle size enlargement by C. E. Capes; Volume 1 ; 1980; Elsevier.

The core of the enzyme granule/particle may be surrounded by at least one coating, e.g., to improve the storage stability, to reduce dust formation during handling, or for coloring the granule.

The optional coating(s) may include a salt coating, or other suitable coating materials, such as polyethylene glycol (PEG), methyl hydroxy-propyl cellulose (MHPC) and polyvinyl alcohol (PVA).

Examples of enzyme granules with multiple coatings are shown in WO 93/07263 and WO

97/23606. The coating may be applied in an amount of at least 0.1 % by weight of the core, e.g., at least 0.5%, 1% or 5%. The amount may be at most 100%, 70%, 50%, 40% or 30%. The coating is preferably at least 0.1 pm thick, particularly at least 0.5 pm, at least 1 pm or at least 5 pm. In a one embodiment, the thickness of the coating is below 100 pm. In another embodiment, the thickness of the coating is below 60 pm. In an even more particular embodiment the total thickness of the coating is below 40 pm. The coating should encapsulate the core unit by forming a substantially continuous layer. A substantially continuous layer is to be understood as a coating having few or no holes, so that the core unit it is encapsulating/enclosing has few or none uncoated areas. The layer or coating should be homogeneous in thickness. The coating can further contain other materials as known in the art, e.g., fillers, antisticking agents, pigments, dyes, plasticizers and/or binders, such as titanium dioxide, kaolin, calcium carbonate or talc. A salt coating may comprise at least 60% by weight w/w of a salt, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 99% by weight w/w. The salt may be added from a salt solution where the salt is completely dissolved or from a salt suspension wherein the fine particles is less than 50 pm, such as less than 10 pm or less than 5 pm. The salt coating may comprise a single salt or a mixture of two or more salts. The salt may be water soluble, and may have a solubility at least 0.1 grams in 100 g of water at 20°C, preferably at least 0.5 g per 100 g water, e.g., at least 1 g per 100 g water, e.g., at least 5 g per 100 g water. The salt may be an inorganic salt, e.g., salts of sulfate, sulfite, phosphate, phosphonate, nitrate, chloride or carbonate or salts of simple organic acids (less than 10 carbon atoms, e.g., 6 or less carbon atoms) such as citrate, malonate or acetate. Examples of cations in these salts are alkali or earth alkali metal ions, the ammonium ion or metal ions of the first transition series, such as sodium, potassium, magnesium, calcium, zinc or aluminium. Examples of anions include chloride, bromide, iodide, sulfate, sulfite, bisulfite, thiosulfate, phosphate, monobasic phosphate, dibasic phosphate, hypophosphite, dihydrogen pyrophosphate, tetraborate, borate, carbonate, bicarbonate, metasilicate, citrate, malate, maleate, malonate, succinate, lactate, formate, acetate, butyrate, propionate, benzoate, tartrate, ascorbate or gluconate. In particular alkali- or earth alkali metal salts of sulfate, sulfite, phosphate, phosphonate, nitrate, chloride or carbonate or salts of simple organic acids such as citrate, malonate or acetate may be used. The salt in the coating may have a constant humidity at 20°C above 60%, particularly above 70%, above 80% or above 85%, or it may be another hydrate form of such a salt (e.g., anhydrate). The salt coating may be as described in WO

00/01793 or WO 2006/034710. Specific examples of suitable salts are NaCI (CH₂o_°c=76%), Na₂C0₃

(CH₂O°C=92%), NaNOs (CH₂o_°c=73%), Na₂HP0₄ (CH₂o_°c=95%), Na₃P0₄ (CH_25°c=92%), NH₄CI

(CH₂O°C = 79.5%), (NH₄)₂HP0₄ (CH₂O°C = 93,0%), NH₄H₂P0₄ (CH₂o°c = 93.1%), (NH₄)₂S0₄ (CH₂o_°c=81.1 %), KCI (CH_2O°C=85%), K₂HP0₄ (CH_20°C=92%), KH₂P0₄ (CH_20°C=96.5%), KNO_S (CH_20°C=93.5%), Na₂S0₄ (CH_20°c=93%), K₂S0₄ (CH_20°c=98%), KHS0₄ (CH_20°c=86%), MgS0₄ (CH_2O°C=90%), ZnS0₄ (CH₂o_°c=90%) and sodium citrate (CH_25°c=86%). Other examples include NaH₂P0₄, (NH₄)H₂P0₄, CUS0₄, Mg(N0₃)₂ and magnesium acetate. The salt may be in anhydrous form, or it may be a hydrated salt, i.e. a crystalline salt hydrate with bound water(s) of crystallization, such as described in WO 99/32595. Specific examples include anhydrous sodium sulfate (Na₂S0₄), anhydrous magnesium sulfate (MgS0₄), magnesium sulfate heptahydrate (MgS0₄7H₂0), zinc sulfate heptahydrate (ZnS0₄7H₂0), sodium phosphate dibasic heptahydrate (Na₂HP0₄7H₂0), magnesium nitrate hexahydrate (Mg(N0₃)₂(6H₂0)), sodium citrate dihydrate and magnesium acetate tetrahydrate. Preferably the salt is applied as a solution of the salt, e.g., using a fluid bed.

One embodiment of the present invention provides a granule, which comprises:

(a) a core comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glucosyl hydrolase classified as Glyco_hydro_1 14 hydrolase and

(b) optionally a coating consisting of one or more layer(s) surrounding the core.

One embodiment of the present invention provides a granule, which comprises:

(a) a core comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase and

One embodiment of the invention relates to a granule, which comprises:

(a) a core comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glucosyl hydrolase classified as Glyco_hydro_1 14 hydrolase, wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence with;

v) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 86, vi) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 87,

xviii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 99,

and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 13, and

One embodiment of the invention relates to a granule, which comprises:

(a) a core comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase, wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence with;

One embodiment of the invention relates to a granule, which comprises:

(a) a core comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as a Glyco_hydro_1 14 hydrolase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence with;

xiv) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 95, xv) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 96,

xviii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 99

and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 65, and

One embodiment of the invention relates to a granule, which comprises:

(a) a core comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence with;

vi) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 87, vii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 88,

(c) optionally a coating consisting of one or more layer(s) surrounding the core.

One embodiment of the invention relates to a granule, which comprises:

(a) a core comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence with;

and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 66, and

One embodiment of the invention relates to a granule, which comprises:

(a) a core comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin and an RNase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence with;

xv) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 96, xvi) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 97,

One embodiment of the invention relates to a granule, which comprises:

(a) a core comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence with;

and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 67, and

(b) optionally a coating consisting of one or more layer(s) surrounding the core. One embodiment of the invention relates to a granule, which comprises:

One embodiment of the invention relates to a granule, which comprises:

(a) a core comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glucosyl hydrolase classified as Glyco_hydro_1 14 hydrolase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence with;

and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 68, and

One embodiment of the invention relates to a granule, which comprises:

Uses

The present invention is also directed to methods for using the cleaning composition in laundry/textile/fabric (household laundry, industrial laundry) or hard surface cleaning (ADW, car wash, industrial surface cleaning)

Use of cleaning composition

The cleaning composition of the present invention may be formulated, for example, as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre- treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations. In a specific aspect, the present invention provides a detergent additive comprising one or more enzymes as described herein.

The compositions of the invention comprise a blend of enzymes including a DNase and a hexosaminidase, and effectively reduce or remove organic components, such as polysaccharide and DNA from surfaces such as textiles and hard surfaces e.g. dishes.

The compositions of the invention comprise a blend of DNase, hexosaminidase, preferably b-N-acetylglucosaminidase, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase or a blend or DNase, hexosaminidase, preferably b-N-acetylglucosaminidase, and RNase. One embodiment of the invention relates to the use of a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase and at least one cleaning component, or a cleaning composition comprising a DNase, a hexosaminidase, preferably a b- N-acetylglucosaminidase e.g. a dispersin, and an RNase and at least one cleaning component for reduction or removal of components e.g. of biofilm, such as polysaccharides, e.g. N-acetyl- glucosaminide e.g. poly-N-acetylglucosamine (PNAG) and DNA, from an item, wherein the item is a textile or a hard surface.

One embodiment of the invention relates to the use of a cleaning composition comprising a DNase, at least one hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase and a cleaning component, or the use of a cleaning composition comprising a DNase, at least one hexosaminidase, preferably a b- N-acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component for deep cleaning of an item, wherein the item is a textile or a surface.

One embodiment of the invention relates to the use of a composition comprising a

DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase, or the use of a composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase for reduction or removal of biofilm and/or compounds such as polysaccharide, e.g. N-acetyl-glucosaminide e.g. poly-N-acetylglucosamine (PNAG) and/or

DNA of an item. One embodiment of the invention relates to the use of a composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase or the use of a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase for reduction or removal of biofilm and/or compounds such as polysaccharide, e.g. N-acetyl-glucosaminide e.g. poly-N-acetylglucosamine (PNAG) and/or DNA from an item such as textile. One embodiment of the invention relates to the use of a composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase, or the use of a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin, and an RNase for deep cleaning when the cleaning composition is applied in e.g. laundry process.

One embodiment of the invention relates to the use of a composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase, or the use of a composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase for reduction of redeposition or reduction of malodor. One embodiment of the invention relates to the use of a composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase, or the use of a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase for reduction of redeposition or reduction of malodor.

One embodiment of the invention relates to the use of a composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase, or the use of a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase for reduction of redeposition or reduction of malodor when the cleaning composition is applied in e.g. a laundry process. One embodiment of the invention relates to the use of a composition comprising a DNase, a hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase or the use of a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase for reduction of redeposition or reduction of malodor on an item e.g. textile. In one embodiment, the composition is an anti-redeposition composition.

DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase or the use of a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase for deep cleaning of an item or reduction of redeposition or malodor, wherein the a hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence having;

One embodiment of the invention relates to the use of a composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase or the use of a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase for deep cleaning of an item or reduction of redeposition or malodor, wherein the a hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence having:

and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 13.

and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 65.

One embodiment of the invention relates to the use of a composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase or the use of a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase for deep cleaning of an item or reduction of redeposition or malodor, wherein the a hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence having: i) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 82,

and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 66.

iv) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 85, v) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 86,

xviii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 99, and

wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 67.

viii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 89, ix) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 90,

wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 68.

The invention further relates to a method of deep cleaning an item, comprising the steps of: a) contacting the item with a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase and a cleaning component, or with a cleaning composition comprising a DNase, a hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin, an RNase and a cleaning component; and b) and optionally rinsing the item,

wherein the item is preferably a textile.

The invention further relates to a method of deep cleaning an item, comprising the steps of: a) contacting the item with a cleaning composition comprising a DNase, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 13, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence having;

ix) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 90, x) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 91 ,

and a cleaning component; and

b) and optionally rinsing the item, wherein the item is preferably a textile.

The invention further relates to a method of deep cleaning an item, comprising the steps of: a) contacting the item with a cleaning composition comprising a DNase, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 13, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase wherein the hexosaminidase is selected from the group consisting of the polypeptides;

and a cleaning component; and

b) and optionally rinsing the item,

wherein the item is preferably a textile.

The invention further relates to a method of deep cleaning an item, comprising the steps of: a) contacting the item with a cleaning composition comprising a DNase, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 65, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence having;

xvii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 98, and xviii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 99,

and a cleaning component; and

b) and optionally rinsing the item,

wherein the item is preferably a textile.

The invention further relates to a method of deep cleaning an item, comprising the steps of: a) contacting the item with a cleaning composition comprising a DNase, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 65, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence having;

and a cleaning component; and

b) and optionally rinsing the item,

wherein the item is preferably a textile.

The invention further relates to a method of deep cleaning an item, comprising the steps of: a) contacting the item with a cleaning composition comprising a DNase, wherein the

DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 66, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycopsyl hydrolase classified as Glyco_hydro_1 14 hydrolase wherein the hexosaminidase is selected from the group consisting of polypeptides; comprising an amino acid sequence having

and a cleaning component; and

b) and optionally rinsing the item,

wherein the item is preferably a textile.

The invention further relates to a method of deep cleaning an item, comprising the steps of: a) contacting the item with a cleaning composition comprising a DNase, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 66, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence having;

and a cleaning component; and

b) and optionally rinsing the item,

wherein the item is preferably a textile.

The invention further relates to a method of deep cleaning an item, comprising the steps of: a) contacting the item with a cleaning composition comprising a DNase, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 66, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence having;

and a cleaning component; and

b) and optionally rinsing the item,

wherein the item is preferably a textile.

and a cleaning component; and

b) and optionally rinsing the item,

wherein the item is preferably a textile.

The invention further relates to a method of deep cleaning an item, comprising the steps of: a) contacting the item with a cleaning composition comprising a DNase, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 67, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence having;

and a cleaning component; and

b) and optionally rinsing the item,

wherein the item is preferably a textile.

The invention further relates to a method of deep cleaning an item, comprising the steps of: a) contacting the item with a cleaning composition comprising a DNase, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 67, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence having;

and a cleaning component; and b) and optionally rinsing the item,

wherein the item is preferably a textile.

The invention further relates to a method of deep cleaning an item, comprising the steps of: a) contacting the item with a cleaning composition comprising a DNase, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 68, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence having;

and a cleaning component; and

b) and optionally rinsing the item,

wherein the item is preferably a textile.

The invention further relates to a method of deep cleaning an item, comprising the steps of: a) contacting the item with a cleaning composition comprising a DNase, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 68, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase wherein the hexosaminidase is selected from the group consisting of polypeptides comprising an amino acid sequence having;

and a cleaning component; and

b) and optionally rinsing the item,

wherein the item is preferably a textile.

The invention further relates to a kit intended for deep cleaning, wherein the kit comprises a solution of an enzyme mixture comprising a DNase, a hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase, or an enzyme mixture comprising a DNase, a hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin and an RNase.

The DNase is preferably selected from polypeptides having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 13, SEQ ID NO 65, SEQ ID NO 66, SEQ ID NO 67 and SEQ ID NO 68, and the hexosaminidase, preferably a b-N- acetylglucosaminidase e.g. a dispersin is preferably selected from the group consisting of polypeptides comprising an amino acid sequence having;

xvi) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 97, xvii) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO: 98, and

The invention is further described in the following paragraphs,

Paragraph 1 A cleaning composition comprising:

a) a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_114 hydrolase; or

b) a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin, and an RNase;

and a cleaning component.

Paragraph 2 A cleaning composition according to paragraph 1 , wherein the DNase is microbial, preferably obtained from bacteria or fungi.

Paragraph 3 A cleaning composition according to paragraph 2, wherein the DNase is obtained from Bacillus, preferably Bacillus cibi, Bacillus horikoshii, Bacillus licheniformis, Bacillus subtilis, Bacillus horneckiae, Bacillus idriensis, Bacillus algicola, Bacillus vietnamensis, Bacillus hwajinpoensis, Bacillus indicus, Bacillus marisflavi or Bacillus luciferensis.

Paragraph 4 A cleaning composition of paragraph 3, wherein the DNase comprises one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74).

Paragraph 5 A cleaning composition according to any of paragraphs 2 to 4, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO 13.

Paragraph 6 A cleaning composition according to any of paragraphs 2 to 4, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO: 65.

Paragraph 7 A cleaning composition according to any of paragraphs 2 to 4, wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO: 66.

Paragraph 8 A cleaning composition according to paragraph 2, wherein the DNase is fungal, preferably obtained from Aspergillus and even more preferably from Aspergillus oryzae, and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO: 67.

Paragraph 9 A cleaning composition according to paragraph 2, wherein the DNase is fungal, preferably obtained from Trichoderma and even more preferably from Trichoderma harzianum, and wherein the DNase has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% sequence identity to the amino acid sequence shown in SEQ ID NO: 68.

Paragraph 10 A cleaning composition according to any of the proceeding paragraphs, wherein the hexosaminidase is selected from the group of hexosaminidases comprising an amino acid sequence with;

Paragraph 1 1 A cleaning composition according to any of the preceding paragraphs, wherein the Glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase is selected from polypeptides comprising an amino acid sequence having:

L) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 1 1 , m) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 12,

bb) least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 127,

Paragraph 12 A cleaning composition according to any of the preceding paragraphs, wherein the

RNase is selected from polypeptides comprising an amino acid sequence having:

a) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 138,

d) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 141 , e) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 142,

r) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 155, and

Paragraph 13 A cleaning composition according to any of the preceding paragraphs wherein the amount of DNase in the composition is from 0.01 to 1000 ppm, the amount of hexosaminidase is from 0.01 to 1000 ppm, the amount of glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase in the composition is from 0.01 to 1000 ppm or the amount of RNase is from 0.01 to 1000 ppm.

Paragraph 14 A cleaning composition according to any of the preceding paragraphs, wherein the cleaning component is selected from surfactants, preferably anionic and/or nonionic, builders and bleach components.

Paragraph 15 Use of a cleaning composition according to any of paragraphs 1 to 14 for deep cleaning of an item, wherein the item is a textile or a surface.

Paragraph 16 A method of formulating a cleaning composition according to any of paragraphs 1 to 1 1 or paragraphs 13-14 comprising combining a DNase, a hexosaminidase, a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase and at least one cleaning component.

Paragraph 17 A method of formulating a cleaning composition according to any of paragraphs 1 to 10 or paragraphs 12-14 comprising combining a DNase, a hexosaminidase, an RNase and at least one cleaning component.

Paragraph 18 A kit intended for deep cleaning, wherein the kit comprises a solution of an enzyme mixture comprising a DNase and a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin e.g. a b-N-acetylglucosaminidase, and a glycosyl hydrolase classified as Glyco_hydro_1 14 hydrolase.

Paragraph 19 A kit intended for deep cleaning, wherein the kit comprises a solution of an enzyme mixture comprising a DNase and a hexosaminidase, preferably a b-N-acetylglucosaminidase e.g. a dispersin e.g. a b-N-acetylglucosaminidase, and an RNase. Paragraph 20 A method of deep cleaning an item, comprising the steps of:

a) contacting the item with a cleaning composition according to any of paragraphs 1 to 14; and

b) optionally rinsing the item,

wherein the item is preferably a textile.

Examples - Assays

Assay I: Testing of DNase activity

DNase activity may be determined on DNase Test Agar with Methyl Green (BD, Franklin Lakes, NJ, USA), prepared according to the manual from the supplier. Briefly, 21 g of agar is dissolved in 500 ml water and then autoclaved for 15 min at 121 °C. Autoclaved agar is temperated to 48°C in water bath, and 20 ml of agar is poured into petri dishes and allowed to solidify by incubation overnight at room temperature. On solidified agar plates, 5 pi of enzyme solutions are added, and DNase activity is observed as colorless zones around the spotted enzyme solutions.

Assay II: Testing of hexosaminidase activity

The hexosaminidase activity of the polypeptides may be determined using 4-nitrophenyl N- acetyl-3-D-glucosaminide (Sigma-Aldrich) as substrate. The enzymatic reaction is performed in triplicate in 96 well flat bottom polystyrene microtiter plates (Thermo Scientific) with the following conditions: 50 mM 2-(N-morpholino)ethanesulfonic acid pH 6 buffer, 1 .5 mg/ml 4-nitrophenyl N- acetyl-3-D-glucosaminide and 20 pg/ml purified enzyme sample in a total reaction volume of 100 pi. Blank samples without polypeptide are run in parallel. The reactions are carried out at 37°C in a Thermomixer comfort (Eppendorf). After 10 minutes of incubation, 5 mI 1 M NaOH is added to each reaction mixture to stop the enzymatic reaction. The absorbance is read at 405 nm using a POLARstar Omega plate reader (BMG LABTECH) to estimate the formation of 4- nitrophenolate ion released due to enzymatic hydrolysis of the 4-nitrophenyl N-acetyl-3-D- glucosaminide substrate.

Assay III: Mini wash assay

Wash performance may be assessed in a laundry wash experiment using a Mini wash assay, which is a test method where soiled textile is continuously lifted up and down in the test solution and subsequently rinsed.

The wash experiment may be conducted under various experimental conditions, one example of which is specified below:

Table 1

Test materials may be obtained from EMPA Testmaterials AG Movenstrasse 12, CH-9015 St. Gallen, Switzerland, from Center for Testmaterials BV, P.O. Box 120, 3133 KT Vlaardingen, the Netherlands, and from WFK Testgewebe GmbH, Christenfeld 10, D-41379 Brijggen, Germany.

After washing and rinsing, the textiles are subsequently air-dried and the wash performance is measured as the brightness of the colour of these textiles. Brightness can also be expressed as the Remission (R), which is a measure for the light reflected or emitted from the test material when illuminated with white light. The Remission (R) of the textiles is measured at 460 nm using a Zeiss MCS 521 VIS spectrophotometer. The measurements are done according to the manufacturer's protocol.

Assay IV: Testing of DNase activity

DNase activity may be determined by using the DNaseAlert™ Kit (11-02-01-04, IDT Intergrated DNA Technologies) according to the supplier’s manual. Briefly, 95 pi DNase sample is mixed with 5 mI substrate in a microtiter plate, and fluorescence is immediately measured using a Clariostar microtiter reader from BMG Labtech (536 nm excitation, 556 nm emission).

Assay V: Testing of RNase activity RNase activity may be determined by fluorescence using a fluorescence-quenched oligonucleotide probe. This probe emits a signal after nuclease degradation according to the manual from the supplier (RNase alert kit, Integrated DNA Technology, Coralville, Iowa, USA). Briefly, RNase is diluted in water, hardness 15°dH, to obtain a concentration of 2 ppm, and 5mI of the substrate is added to 95 mI of the RNase sample. The kinetic curve is measured for 10 min at 22°C using a Clariostar microplate reader (excitation 490nm, emission at 520nm).

Claims

1. A cleaning composition comprising:

a) a DNase, a hexosaminidase, preferably a b-N-acetylglucosaminidase, e.g. a dispersin, and a glycosyl hydrolase classified as Glyco_hydro_114 hydrolase; or

and a cleaning component.

2. The cleaning composition according to claim 1 , wherein the DNase is selected among polypeptides of the GYS clade having DNase activity, optionally wherein the polypeptides comprise one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 73) or ASXNRSKG (SEQ ID NO: 74)

3. The cleaning composition according to claim 1 or 2, wherein the DNase is selected from the group consisting of:

k) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 11 , L) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 12,

m) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13,

y) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 25,

and combinations thereof.

4. The cleaning composition according to claim 1 , wherein the DNase is a NUC1 or NUC1 A DNase and comprises one or both of the motifs [V/I]PL[S/A]NAWK (SEQ ID NO: 75) or NPQL (SEQ ID NO: 76).

5. The cleaning composition according to claim 1 or 4, wherein the DNase is selected from the group consisting of:

a) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 26, b) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 27,

m) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 38,

and combinations thereof.

6. The cleaning composition according to claim 1 , wherein the DNase is a NUC1 or NUC1 A DNase and comprises one or both of the motifs P[Q/E]L[W/Y] (SEQ ID NO: 77) or [K/H/E]NAW (SEQ ID NO: 78).

7. The cleaning composition according to claim 1 or 6, wherein the DNase is selected from the group consisting of:

c) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 41 , d) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 42,

m) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 51 ,

and combinations thereof.

8. The cleaning composition according to claim 1 , wherein the DNase is selected from the group consisting of:

a) a polypeptide obtainable from Bacillus licheniformis and having a sequence identity to the polypeptide shown in SEQ ID NO: 65 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which has DNase activity,

b) a polypeptide obtainable from Bacillus subtilis and having a sequence identity to the polypeptide shown in SEQ ID NO: 66 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which has DNase activity, c) a polypeptide obtainable from Aspergillus oryzae and having a sequence identity to the polypeptide shown in SEQ ID NO: 67 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which has DNase activity, d) a polypeptide obtainable from Trichoderma harzianum and having a sequence identity to the polypeptide shown in SEQ ID NO: 68 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% and which has DNase activity,

and combinations thereof.

9. The cleaning composition of any of claims 1 to 8, wherein the hexosaminidase is selected from the group consisting of:

a) a polypeptide having hexosaminidase activity selected from the group consisting of: a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 82, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 83, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 84, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 85, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 86, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 87, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 88, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 89, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 90, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 91 , a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 92, a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 93; a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 94; a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 95; a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 96; a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 97; a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 98; a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 99;

b) a polypeptide having N-acetylglucosaminidase activity, preferably b-N- acetylglucosaminidase activity; and

c) a polypeptide comprising a GH20 domain,

and combinations thereof.

10. The cleaning composition according to any of the preceeding claims, wherein the glycosyl hydrolase classified as Glyco_hydro_114 hydrolase is selected from the group consisting of polypeptides having: a) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 100,

G) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 1 17,

1 1 . The cleaning composition according to any of the claims 1 -10, wherein the RNase is selected from the group consisting of polypeptides having:

e) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 142, f) at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 143,

at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99% or 100% sequence identity to the polypeptide shown in SEQ ID NO 155, and

12. The cleaning composition according to any of the preceding claims, further comprising a protease, e.g. a protease selected from:

i) a protease variant of a protease parent, wherein the protease variant comprises an alteration compared to a protease shown in SEQ ID NO 79 or SEQ ID NO 80 in one or more of the following positions: 3, 4, 9, 15, 24, 27, 42, 55, 59, 60, 66, 74, 85, 96, 97, 98, 99, 100, 101 , 102, 104, 116, 1 18, 121 , 126, 127, 128, 154, 156, 157, 158, 161 , 164, 176, 179, 182, 185, 188, 189, 193, 198, 199, 200, 203, 206, 211 , 212, 216, 218, 226, 229, 230, 239, 246, 255, 256, 268 and 269, wherein the positions correspond to the positions of the protease shown in SEQ ID NO 79, and wherein the protease variant has at least 80% sequence identity to SEQ ID NO 79 or SEQ ID NO 80;

ii) a protease variant of a protease parent, wherein the protease variant comprises one or more mutations selected from the group consisting of S3T, V4I, S9R, S9E, A15T, S24G, S24R, K27R, N42R, S55P, G59E, G59D, N60D, N60E, V66A, N74D, S85R, A96S, S97G, S97D, S97A, S97SD, S99E, S99D, S99G, S99M, S99N, S99R, S99H, S101A, V102I, V102Y, V102N, S104A, G116V, G1 16R, H118D, H1 18N, A120S, S126L, P127Q, S128A, S154D, A156E, G157D, G157P, S158E, Y161A, R164S, Q176E, N179E, S182E, Q185N, A188P, G189E, V193M, N198D, V199I, Y203W, S206G, L211 Q, L21 1 D, N212D, N212S, M216S, A226V, K229L, Q230H, Q239R, N246K, N255W, N255D, N255E, L256E, L256D T268A and R269H, wherein positions correspond to the positions of the protease shown in SEQ ID NO 79, and wherein the protease variant has at least 80% sequence identity to SEQ ID NO 79 or SEQ ID NO 80;

iii) a protease comprising a substitution at one or more positions corresponding to positions 171 , 173, 175, 179, or 180 of SEQ ID NO: 81 , compared to the protease shown in SEQ ID NO 81 , wherein the protease variant has a sequence identity of at least 75% but less than 100% to amino acid 1 to 31 1 of SEQ ID NO 81 ; and iv) a protease comprising the amino acid sequence shown in SEQ ID NO 79, SEQ ID NO 80 or SEQ ID NO 81 , or a protease having at least 80% sequence identity to the polypeptide comprising amino acids 1-269 of SEQ ID NO 79, the polypeptide comprising amino acids 1-311 of SEQ ID NO 81 or the polypeptide comprising amino acids 1-275 of SEQ ID NO 80.

13. The use of the cleaning composition according to any of the previous claims for cleaning of an item, wherein the item is a textile or a surface.

14. A kit intended for cleaning, wherein the kit comprises a solution of an enzyme mixture comprising a DNase, a hexosaminidase and a glycosyl hydrolase classified as Glyco_hydro_114 hydrolase, or the kit comprises a solution of an enzyme mixture comprising a DNase, a hexosaminidase and an RNase.

15. A method of cleaning an item, comprising the steps of:

a) contacting the item with a wash liquor solution comprising an enzyme mixture comprising at least 0.0001 ppm of a DNase, at least 0.0001 ppm of a hexosaminidase, preferably a b-N-acetylglucosaminidase, e.g. a dispersin, at least 0.0001 ppm of a glycosyl hydrolase classified as Glyco_hydro_114 hydrolase, and a cleaning component; or with a wash liquor solution comprising an enzyme mixture comprising at least 0.0001 ppm of a DNase, at least 0.0001 ppm of a hexosaminidase, preferably a b-N- acetylglucosaminidase, e.g. a dispersin, at least 0.0001 ppm of an RNase, and a cleaning component; wherein the cleaning component comprises at least a surfactant and optionally comprises a builder and/or a bleach component; and

b) optionally rinsing the item,

wherein the item is preferably a textile.